var title_f35_18_36128="Rectal cancer BE";
var content_f35_18_36128=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82202%7EGAST%2F75818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82202%7EGAST%2F75818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rectal cancer as seen on barium enema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 247px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Double-contrast barium enema shows an eccentric mass arising from the anterior wall of the rectum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cancer of the colon as seen on barium enema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 245px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Double contrast barium enema shows an apple-core lesion surrounding the lumen of the descending colon.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36128=[""].join("\n");
var outline_f35_18_36128=null;
var title_f35_18_36129="Patient information: Appendicitis in adults (The Basics)";
var content_f35_18_36129=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15784\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/8/34946\">",
"         Appendicitis",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?3/37/3666\">",
"         Patient information: Appendicitis in children (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Appendicitis in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/appendicitis-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H13395338\">",
"      <span class=\"h1\">",
"       What is the appendix?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The appendix is a long, thin pouch that is shaped like a finger. It hangs down from the large intestine, or colon (",
"      <a class=\"graphic graphic_figure graphicRef81580 \" href=\"mobipreview.htm?34/8/34946\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13395345\">",
"      <span class=\"h1\">",
"       What is appendicitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Appendicitis is the name for when the appendix gets infected and inflamed. If that happens, the pouch can swell and in some cases burst. That&rsquo;s dangerous, because a burst appendix can cause widespread infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13395352\">",
"      <span class=\"h1\">",
"       What are the symptoms of appendicitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The usual symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Severe pain in the lower part of the belly, on the right side. (For many people, the pain starts near the belly button and then moves to the lower right side.)",
"       </li>",
"       <li>",
"        Loss of appetite",
"       </li>",
"       <li>",
"        Nausea and vomiting",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people have a different set of symptoms that include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Stomach upset",
"       </li>",
"       <li>",
"        Having a lot of gas",
"       </li>",
"       <li>",
"        Irregular bowel movements",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"       <li>",
"        Feeling ill",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13395359\">",
"      <span class=\"h1\">",
"       Is there a test for appendicitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse can run tests that can help him or her find the cause of your symptoms. But if you do have appendicitis, he or she will probably be able to diagnose it just by doing an exam. Your doctor or nurse can learn a lot about your condition by pressing on your belly and talking with you about your symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13395366\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Call your doctor or nurse if you have the symptoms listed above.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13395373\">",
"      <span class=\"h1\">",
"       How is appendicitis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main treatment for appendicitis is surgery to remove the appendix. This surgery can be done in 2 ways:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Open surgery",
"        </strong>",
"        &mdash; During an open surgery, the doctor makes a cut near the appendix that is big enough to pull the appendix through.",
"       </li>",
"       <li>",
"        <strong>",
"         Laparoscopic surgery",
"        </strong>",
"        &mdash; During laparoscopic surgery, the doctor makes a few cuts that are much smaller than those used in open surgery. Then he or she inserts long, thin tools into the belly. One of the tools has a camera (called a &ldquo;laparoscope&rdquo;) on the end, which sends pictures to a TV screen. The doctor can look at the image on the screen to know where to cut and what to remove. Then he or she uses the long tools to do the surgery.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your appendix has burst, your surgery will probably be more complicated than it would be if it had not burst. Your doctor will need to wash away the material that spills out when an appendix bursts. As a result, your cuts may be larger or you may spend more time in surgery.",
"     </p>",
"     <p>",
"      If it has been a few days since your appendix burst, your doctor might decide not to do surgery at all. That&rsquo;s because the body sometimes forms a wall inside the belly, to block off the area that became infected when the appendix burst. In cases like that, doctors usually give antibiotics and carefully watch people. But they often avoid surgery, because it can be dangerous in people who fit this description.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13395380\">",
"      <span class=\"h1\">",
"       What if I am pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you are pregnant and think you have signs of appendicitis, make sure you tell your doctors that you are pregnant.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H3292292\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/37/3666?source=see_link\">",
"       Patient information: Appendicitis in children (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?35/18/36129?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15784 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-89.32.226.102-21F53BA666-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36129=[""].join("\n");
var outline_f35_18_36129=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395338\">",
"      What is the appendix?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395345\">",
"      What is appendicitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395352\">",
"      What are the symptoms of appendicitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395359\">",
"      Is there a test for appendicitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395366\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395373\">",
"      How is appendicitis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13395380\">",
"      What if I am pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3292292\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15784\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/8/34946\">",
"      Appendicitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/37/3666?source=related_link\">",
"      Patient information: Appendicitis in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_18_36130="Patient information: Pneumonia in adults (The Basics)";
var content_f35_18_36130=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15374\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/3/10294\">",
"         Pneumonia",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?12/29/12754\">",
"         Patient information: Community-acquired pneumonia in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?42/0/43011\">",
"         Patient information: Cough in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?13/7/13427\">",
"         Patient information: Cough in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/55/18291\">",
"         Patient information: Cough, runny nose, and the common cold (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/40/40578\">",
"         Patient information: Fever in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/47/33522\">",
"         Patient information: Flu (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/1/19474\">",
"         Patient information: Hospital-acquired pneumonia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/24/7554\">",
"         Patient information: Pneumocystis pneumonia (PCP) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?11/48/12035\">",
"         Patient information: Vaccines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/31/36338\">",
"         Patient information: When to worry about a fever (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/38/30308\">",
"         Patient information: Pneumonia in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?13/57/14225\">",
"         Patient information: Pneumonia prevention (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pneumonia in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pneumonia-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H396302540\">",
"      <span class=\"h1\">",
"       What is pneumonia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pneumonia is an infection of the lungs that causes coughing, fever, and trouble breathing (",
"      <a class=\"graphic graphic_figure graphicRef55943 \" href=\"mobipreview.htm?10/3/10294\">",
"       figure 1",
"      </a>",
"      ). It is a serious illness, especially in young children, people older than 65, and people with other health problems. Pneumonia is usually caused by bacteria but can also be caused by viruses or other germs.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302491\">",
"      <span class=\"h1\">",
"       What are the symptoms of pneumonia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Common symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Cough",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Trouble breathing",
"       </li>",
"       <li>",
"        Pain when you take a deep breath",
"       </li>",
"       <li>",
"        A fast heartbeat",
"       </li>",
"       <li>",
"        Shaking chills",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      When people with pneumonia cough, they often cough up phlegm or mucus.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302498\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse if I think I have pneumonia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, see a doctor or nurse as soon as possible.",
"      <strong>",
"      </strong>",
"      Pneumonia can be mild. But it can also be very serious, especially if you do not get it treated right away. See your doctor or nurse if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Your cough keeps getting worse",
"       </li>",
"       <li>",
"        You start having trouble breathing when doing everyday tasks or when resting",
"       </li>",
"       <li>",
"        You have a fever of 102&deg;F (or 38.8&deg;C) or higher",
"       </li>",
"       <li>",
"        You have chest pain when you breathe in",
"       </li>",
"       <li>",
"        You feel suddenly worse after getting better from a cold or the flu",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your doctor or nurse thinks you might have pneumonia, he or she will probably take an x-ray of your chest. Taking a chest x-ray is the best way to tell if you have pneumonia.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302505\">",
"      <span class=\"h1\">",
"       How is pneumonia treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pneumonia that is caused by bacteria is treated with antibiotics. These medicines kill the germs that cause pneumonia. Most people can take antibiotic pills at home, but some people need to be treated in the hospital. Make sure to take all of your antibiotics, even if you feel better before you finish them!",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302512\">",
"      <span class=\"h1\">",
"       How soon will I feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should start to feel better 3 to 5 days after you start taking antibiotics. Most people can get back to their normal routine within a week of starting treatment. Even so, you might feel tired or have a cough for up to a month after you get treated.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302519\">",
"      <span class=\"h1\">",
"       How should I take care of myself until I recover?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Get lots of rest and drink lots of fluids. See your doctor or nurse 4 to 6 weeks after you get better. He or she will want to make sure everything is back to normal.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302526\">",
"      <span class=\"h1\">",
"       What can I do to keep from getting pneumonia again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can wash your hands often with soap and water, or use alcohol hand rubs. Doing so will help protect you from germs.",
"     </p>",
"     <p>",
"      There is also a vaccine against the most common type of bacterial pneumonia. But the vaccine is not for everyone. Ask your doctor if it is right for you. Most people should also get a flu vaccine every year.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H396302533\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/29/12754?source=see_link\">",
"       Patient information: Community-acquired pneumonia in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/1/19474?source=see_link\">",
"       Patient information: Hospital-acquired pneumonia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/24/7554?source=see_link\">",
"       Patient information: Pneumocystis pneumonia (PCP) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/55/18291?source=see_link\">",
"       Patient information: Cough, runny nose, and the common cold (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/40/40578?source=see_link\">",
"       Patient information: Fever in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/47/33522?source=see_link\">",
"       Patient information: Flu (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/48/12035?source=see_link\">",
"       Patient information: Vaccines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/0/43011?source=see_link\">",
"       Patient information: Cough in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/7/13427?source=see_link\">",
"       Patient information: Cough in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/31/36338?source=see_link\">",
"       Patient information: When to worry about a fever (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?29/38/30308?source=see_link\">",
"       Patient information: Pneumonia in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/57/14225?source=see_link\">",
"       Patient information: Pneumonia prevention (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?35/18/36130?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15374 Version 10.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-D91D1357DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36130=[""].join("\n");
var outline_f35_18_36130=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302540\">",
"      What is pneumonia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302491\">",
"      What are the symptoms of pneumonia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302498\">",
"      Should I see a doctor or nurse if I think I have pneumonia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302505\">",
"      How is pneumonia treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302512\">",
"      How soon will I feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302519\">",
"      How should I take care of myself until I recover?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302526\">",
"      What can I do to keep from getting pneumonia again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H396302533\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15374\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/3/10294\">",
"      Pneumonia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/29/12754?source=related_link\">",
"      Patient information: Community-acquired pneumonia in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/0/43011?source=related_link\">",
"      Patient information: Cough in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/7/13427?source=related_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/55/18291?source=related_link\">",
"      Patient information: Cough, runny nose, and the common cold (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/47/33522?source=related_link\">",
"      Patient information: Flu (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/1/19474?source=related_link\">",
"      Patient information: Hospital-acquired pneumonia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/24/7554?source=related_link\">",
"      Patient information: Pneumocystis pneumonia (PCP) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?29/38/30308?source=related_link\">",
"      Patient information: Pneumonia in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/57/14225?source=related_link\">",
"      Patient information: Pneumonia prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/48/12035?source=related_link\">",
"      Patient information: Vaccines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/31/36338?source=related_link\">",
"      Patient information: When to worry about a fever (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_18_36131="Severe herpes zoster in cancer";
var content_f35_18_36131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated herpes zoster",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 257px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Severe vesiculopustular lesions on erythematous bases present in multiple dermatomes in this patient with squamous cell carcinoma of the vocal cord.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles V Sanders, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36131=[""].join("\n");
var outline_f35_18_36131=null;
var title_f35_18_36132="Nail anatomy 2";
var content_f35_18_36132=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85578&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85578&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Nail anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36132=[""].join("\n");
var outline_f35_18_36132=null;
var title_f35_18_36133="Imipramine: Patient drug information";
var content_f35_18_36133=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Imipramine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/41/41624?source=see_link\">",
"     see \"Imipramine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/5/31831?source=see_link\">",
"     see \"Imipramine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tofranil-PM&reg;;",
"     </li>",
"     <li>",
"      Tofranil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Imipramine&reg;;",
"     </li>",
"     <li>",
"      Novo-Pramine;",
"     </li>",
"     <li>",
"      Tofranil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691590",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease long-term pain problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691728",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anxiety.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692010",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat panic attacks.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702295",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to imipramine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703749",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a recent heart attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4232023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any of these drugs: Linezolid or methylene blue.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697797",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have some heart tests before starting this drug. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an overactive thyroid, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695854",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime if it causes sleepiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695723",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tablet can be crushed and mixed with food or liquid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10757 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-218.189.88.190-50AA3700D9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36133=[""].join("\n");
var outline_f35_18_36133=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182136\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182137\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020332\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020334\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020333\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020338\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020339\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020341\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020336\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020337\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020342\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020343\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/41/41624?source=related_link\">",
"      Imipramine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/5/31831?source=related_link\">",
"      Imipramine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_18_36134="Acute liver failure - high power";
var content_f35_18_36134=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute liver failure (high power, Masson trichrome stain)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The only cells visible are macrophages, many filled with yellow-brown pigment granules. Lipofuscin (often called \"wear and tear pigment\") is composed of lipid-containing residues of lysosomal digestion. Its presence in high concentration in macrophages suggests extensive liver cell necrosis. The blue structures are all that remains of sinusoidal membranes that normally surround the hepatic plates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36134=[""].join("\n");
var outline_f35_18_36134=null;
var title_f35_18_36135="Right arch compression CXR";
var content_f35_18_36135=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82725%7EPULM%2F63747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82725%7EPULM%2F63747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Type II right aortic arch with aberrant left subclavian artery compressing the trachea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 308px; height: 450px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph from a woman treated for asthma for many years prior to diagnosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital tracheal stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 344px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Contrast tracheobronchogram from a seven-year-old boy with congenital tracheal stenosis. The lower trachea and both mainstem bronchi are narrow. A tracheal bronchus connecting the trachea directly with the right upper lobe is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36135=[""].join("\n");
var outline_f35_18_36135=null;
var title_f35_18_36136="Clubfoot1";
var content_f35_18_36136=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79257%7EOBGYN%2F59703%7EOBGYN%2F72507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79257%7EOBGYN%2F59703%7EOBGYN%2F72507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clubfoot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plantar surface of the entire fetal right foot can be seen in the same plane as the fibula and tibia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Urania Magriples, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sonogram of fetal clubfoot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plantar surface of the entire fetal right foot can be seen in the same plane as the fibula and tibia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Urania Magriples, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sonogram of fetal clubfoot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The plantar surface of the entire fetal right foot can be seen in the same plane as the fibula and tibia. This fetus is one of a twin pair; the other twin did not have any abnormalities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Urania Magriples, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36136=[""].join("\n");
var outline_f35_18_36136=null;
var title_f35_18_36137="Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology";
var content_f35_18_36137=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/18/36137/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36137/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/18/36137/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36137/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/18/36137/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36137/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/18/36137/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clostridium difficile is the causative organism of antibiotic-associated colitis. Colonization of the intestinal tract occurs via the fecal-oral route and is facilitated by disruption of normal intestinal flora due to antimicrobial therapy. The organism is capable of elaborating exotoxins that bind to receptors on intestinal epithelial cells, leading to inflammation and diarrhea (",
"    <a class=\"graphic graphic_figure graphicRef51819 \" href=\"mobipreview.htm?1/13/1245\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=see_link\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Our understanding of C. difficile microbiology and epidemiology is changing rapidly. Issues related to C. difficile microbiology and epidemiology will be reviewed here. Clinical manifestations, diagnosis, and prevention and treatment of C. difficile are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=see_link\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12184?source=see_link\">",
"     \"Prevention and control of Clostridium difficile in hospital and institutional settings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/29/20954?source=see_link\">",
"     \"Clostridium difficile in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/1\">",
"     1",
"    </a>",
"    ]. In 1978, Clostridium difficile was identified as the causative pathogen in the majority of cases, and the earliest cases of C. difficile were attributed largely to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Increasing use of penicillins and cephalosporins subsequently led to the implication of these antibiotic classes, although clindamycin remains an important culprit. Between 1989 and 1992, a strain of C. difficile highly resistant to clindamycin (the \"J strain\") was implicated in large outbreaks of diarrhea in four hospitals in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/3\">",
"     3",
"    </a>",
"    ]. The use of clindamycin is a specific risk factor for this strain, and colonization with the clindamycin resistant strain increases the risk for developing C. difficile-associated diarrhea (CDAD).",
"   </p>",
"   <p>",
"    From 2003 to 2006, C. difficile infections were observed to be more frequent, severe, refractory to standard therapy, and likely to relapse than previously described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/1\">",
"     1",
"    </a>",
"    ]. These observations have occurred throughout North America and Europe and have been attributed to a new strain designated BI, NAP1, or ribotype 027 (these designations are based on different methods for strain typing and all refer to the same strain, known as strain",
"    <span class=\"nowrap\">",
"     NAP1/BI/027).",
"    </span>",
"    This strain appears to be more virulent than other strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/4\">",
"     4",
"    </a>",
"    ], which may be attributable to increased toxin production compared to conventional strains. Fluoroquinolone use has strongly correlated with the emergence of this strain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/5\">",
"     5",
"    </a>",
"    ], and acquisition of antibiotic resistance by outbreak strains appears to have contributed to the increasing frequency of CDAD outbreaks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Hypervirulent strain: NAP1/BI/027'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In Quebec, Canada, an increase in the frequency and severity of CDAD was observed in the early 2000s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. A retrospective review of 1771 cases from this region demonstrated that in 2003, the incidence of CDAD per 100,000 had increased fourfold since 1991; the incidence had risen 10-fold for individuals over 65 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/8\">",
"     8",
"    </a>",
"    ]. Among hospitalized patients, the incidence increased from 3 to 12 per 1000 persons (1991-2002) to 25 to 43 per 1000 persons (2003-2004). These cases were more serious and refractory to therapy with significant rates of toxic megacolon and disease requiring colectomy. Ten percent of cases required admission to an intensive care and 2.5 percent underwent an emergency colectomy; the mortality was 16 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concurrent with the Quebec outbreak, the Centers for Disease Control and Prevention noted reports of increasing frequency and severity of C. difficile in the United States, including eight hospital outbreaks in six states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. After reports of these emerging outbreaks in Canada and in the United States, CDAD due to the same implicated strain was also detected in Europe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Between 1999 and 2007 in the United States, C. difficile was the main contributor to gastroenteritis-associated deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since 2005, C. difficile infection due to ribotype 078 has emerged in the Netherlands. Patients with disease due to this type present with similar severity as those with type 027, although type 078 appears to affect a younger population, is more frequently community associated, and is genetically similar to porcine isolates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Control strategies depend on improved understanding of C. difficile molecular epidemiology in health care facilities, which appears to be dynamic and diverse. In a longitudinal analysis of C. difficile strains isolated in a single institution between 1982 and 1991, not all epidemiologic fluctuations could be attributed to emergence of the epidemic BI strain, since treatment failure and relapse were also associated with non-BI strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/16\">",
"     16",
"    </a>",
"    ]. The predominant C. difficile organisms varied over the study period, suggesting a changing population that was probably the result of introduction of new strains by patients admitted to the institution.",
"   </p>",
"   <p>",
"    Subsequently, a cross-sectional study demonstrated that ribotype may not be a significant predictor of severe CDAD. Among 310 CDAD cases, including 34 severe cases, the association between ribotypes 027 and 078 was not significant after adjustment for other covariables [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Nosocomial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dramatic increases in the incidence and severity of healthcare-associated C. difficile infection have occurred over since 2000, particularly in patients over age 65 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/18\">",
"     18",
"    </a>",
"    ]. As an example, the rate of nosocomial C. difficile-associated diarrhea (CDAD) in the United States doubled from 31 per 100,000 to 61 per 100,000 between 1996 and 2003 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/19\">",
"     19",
"    </a>",
"    ]. The rate was significantly higher in patients older than 65 (228 per 100,000). In Canada, the attributable mortality rate of healthcare-associated C. difficile infection increased almost fourfold between 1997 and 2005 (5.7 versus 1.5 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C. difficile carriage occurs in 20 to 50 percent of adults in hospitals and long-term care facilities (the carrier rate among healthy adults is about 3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. About 20 percent of patients with negative admission stool cultures become infected during their hospitalization. Although asymptomatic, these individuals are capable of shedding pathogenic organisms and serve as a reservoir for environmental contamination to other hospitalized patients. C difficile is highly transmissible via fomites and can be cultured readily from nearly any surface, including items in patient rooms as well as the hands, clothing, and stethoscopes of healthcare workers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Infection is also transmitted readily between hospital roommates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/21,25\">",
"     21,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    New exposure to C. difficile is more likely to lead to CDAD, while patients previously colonized with C. difficile are more likely to remain asymptomatic during their hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. The magnitude of this difference was illustrated in a prospective review of 810 hospitalizations, including 618 patients with new C. difficile exposure and 192 patients with previous C. difficile colonization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/27\">",
"     27",
"    </a>",
"    ]. Newly exposed patients developed CDAD much more frequently than colonized patients (4.5 versus 1.1 percent).",
"   </p>",
"   <p>",
"    These phenomena have been observed even when carriers and symptomatic patients are colonized with identical strains. In addition, outbreaks are frequently caused by a single strain of C. difficile even though many bacterial strains may exist in the given hospital environment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/28\">",
"     28",
"    </a>",
"    ]. As an example, two outbreaks in the same hospital were attributed to a single strain, although 31 distinct strains were isolated from 98 patients in the institution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some potential explanations for these epidemiologic observations are discussed below. Careful adherence to infection control policies is critical to the control of C. difficile. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Pathophysiology'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19658?source=see_link\">",
"     \"General principles of infection control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic use is the most widely recognized and modifiable risk factor for CDAD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Other established risk factors include hospitalization, advanced age, and severe illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/31\">",
"     31",
"    </a>",
"    ]. Possible additional risk factors include gastric acid suppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/31\">",
"     31",
"    </a>",
"    ], enteral feeding, gastrointestinal surgery, cancer chemotherapy, and hematopoietic stem cell transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/1,32-34\">",
"     1,32-34",
"    </a>",
"    ]. The association between cancer chemotherapy and C. difficile infection may be related to the antimicrobial effect of chemotherapeutic agents",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    their immunosuppressive effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CDAD can also occur in the absence of any risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two major roles for antibiotics in the pathogenesis of C. difficile have been described. First, antibiotics disrupt normal colonic flora, providing a niche for C. difficile to multiply and elaborate toxins. In a small series of patients with CDAD, for example, absence of Bacteroides species (a predominant species in normal colonic flora) was noted during CDAD but returned following resolution of symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/37\">",
"     37",
"    </a>",
"    ]. Second, development of C. difficile antibiotic resistance to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    or fluoroquinolones appears to play an important role in disease due to strains with increased virulence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/3,5\">",
"     3,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The antibiotics most frequently implicated in predisposition to CDAD include fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , and broad-spectrum penicillins and cephalosporins (",
"    <a class=\"graphic graphic_table graphicRef55479 \" href=\"mobipreview.htm?24/35/25147\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/3,5,38,39\">",
"     3,5,38,39",
"    </a>",
"    ]. However, any antibiotic can predispose to colonization by C. difficile, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , which are the major antibiotics used to treat C. difficile infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/40\">",
"     40",
"    </a>",
"    ]. The use of broad-spectrum antimicrobials, use of multiple antibiotic agents, and increased duration of antibiotic therapy all contribute to the incidence of CDAD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The earliest cases of C. difficile were attributed to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    and it remains an important culprit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/1,43\">",
"     1,43",
"    </a>",
"    ]. As noted above, a strain of C. difficile highly resistant to clindamycin (the \"J strain\") was implicated in large outbreaks in the early 1990s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/3\">",
"     3",
"    </a>",
"    ]. The use of clindamycin is a specific risk factor for this strain, and colonization with the clindamycin-resistant strain increases risk for developing CDAD.",
"   </p>",
"   <p>",
"    Increasingly widespread use of fluoroquinolones has been correlated with C. difficile-associated diarrhea. In addition, fluoroquinolone resistance of the hypervirulent strain",
"    <span class=\"nowrap\">",
"     NAP1/BI/027",
"    </span>",
"    may be an important factor in its increased virulence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Hypervirulent strain: NAP1/BI/027'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The degree and duration of CDAD risk after cessation of antibiotic treatment are not well understood. One case-control study including 337 patients with C. difficile suggested that risk was increased during antibiotic therapy and in the period of three months after cessation of therapy; the risk was highest during and in the first month after antibiotic use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Perioperative antibiotic prophylaxis also confers risk for C. difficile, especially if a hospital is experiencing epidemic C. difficile infections. When the only purpose of perioperative prophylaxis is to prevent infrequent and relatively benign infections, the risks may outweigh the benefits in some elderly patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     Doxycycline",
"    </a>",
"    may be associated with diminished risk of C. difficile infection in the setting of co-administration with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    for treatment of community acquired pneumonia; further study is needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Advanced age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advanced age seems to promote the frequency and severity of CDAD. In the 2002 Quebec outbreak, frequency of CDAD among persons &ge;65 years was 10-fold higher than observed in younger adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/9\">",
"     9",
"    </a>",
"    ]. This association was also noted as early as the 1980s, prior to the epidemic emergence of hypervirulent C. difficile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reasons for this association are uncertain and may be multifactorial. Host factors such as diminished immune response to C. difficile infection may play a role. Alternatively, older individuals may have other comorbidities that place them at a cumulative increased risk for C. difficile, such as greater likelihood to require hospitalization or antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Gastric acid suppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proton pump inhibitors (PPIs) have been associated with an increased risk of CDAD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/49-54\">",
"     49-54",
"    </a>",
"    ]. The United States Food and Drug Administration (FDA) issued a drug safety communication in 2012 following a review of published literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/55\">",
"     55",
"    </a>",
"    ]. Most studies reviewed found that the risk of C. difficile infection or disease, including CDAD, ranged from 1.4 to 2.75 times higher among patients with PPI exposure compared to those without PPI exposure. The relationship between the risk of C. difficile infection or CDAD and PPI dose and duration of use is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Community-associated infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of community-associated C. difficile infection (defined as disease in patients not hospitalized in the year prior to diagnosis) is also increasing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/49,50,56\">",
"     49,50,56",
"    </a>",
"    ]. In a study of all confirmed cases of CDAD in a Minnesota county from 1991 through 2005, the incidence of both community-acquired and hospital-acquired infection increased dramatically during the study period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/56\">",
"     56",
"    </a>",
"    ]. Of all 385 cases, 41 percent were community-acquired. Patients with community-acquired disease were younger (median age 50 versus 72), healthier, and more likely to be female (76 versus 60 percent). They were also less likely to have antibiotic exposure (78 versus 94 percent), to be on acid suppressants (22 versus 47 percent), to have cancer (17 versus 32 percent), or to have severe infection (20 versus 31 percent). Risk for recurrence did not differ between the two groups (28 and 30 percent).",
"   </p>",
"   <p>",
"    Unusually severe CDAD has been reported in populations previously thought to be at low risk, including peripartum women and healthy individuals living in the community without a history of antibiotic use, recent hospitalization, or other risk factors for C. difficile-associated disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/50,57,58\">",
"     50,57,58",
"    </a>",
"    ]. As a result, consideration of C. difficile-associated infection is warranted even in the absence of antibiotic exposure or recent hospitalization. Retail food products and domestic animals have been postulated as emerging sources of C. difficile infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clostridium difficile is an anaerobic gram-positive, spore-forming, toxin-producing bacillus first described in 1935 (",
"    <a class=\"graphic graphic_picture graphicRef56042 \" href=\"mobipreview.htm?38/24/39310\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/60\">",
"     60",
"    </a>",
"    ]. It was named \"difficult clostridium\" because of difficulty related to its isolation and growth on conventional media. C. difficile can exist in spore and vegetative forms. Outside the colon, it survives in spore form; spores are resistant to heat, acid, and antibiotics. Once spores are in the colon, they convert to their fully functional vegetative, toxin-producing forms and become susceptible to killing by antimicrobial agents.",
"   </p>",
"   <p>",
"    C. difficile was initially observed as a component of the intestinal flora in healthy newborns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/60\">",
"     60",
"    </a>",
"    ]. The pathogenic role of C. difficile was first appreciated in the 1970s when C. difficile toxin was observed in the stools of patients with antibiotic-associated pseudomembranous colitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/2,61\">",
"     2,61",
"    </a>",
"    ]. This organism is now recognized as the cause of pseudomembranous colitis and other variant forms of diarrhea and colitis in patients exposed to antibiotics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=see_link\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. difficile releases two potent exotoxins that mediate colitis and diarrhea: toxin A (\"enterotoxin\") and toxin B (\"cytotoxin\"). These toxins contain a series of contiguous repeated units at the carboxyl terminus. For toxin A, this region is important for toxin A carbohydrate receptor binding to facilitate intracellular transport as well as for antibody binding in the enzyme-linked immunosorbent assay (ELISA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/62\">",
"     62",
"    </a>",
"    ]. The toxin B receptor(s) have not yet been identified.",
"   </p>",
"   <p>",
"    Once intracellular, toxins A and B inactivate regulatory pathways mediated by Rho family proteins that are involved in cytoskeleton structure and signal transduction via guanosine triphosphate (GTP). This disruption leads to cell retraction and apoptosis (grossly visible as cell rounding in tissue culture assays and as shallow ulceration on the intestine mucosal surface) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Both toxins also disrupt intercellular tight junctions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=see_link&amp;anchor=H6#H6\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\", section on 'Endoscopic findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In vivo, stool toxin levels correlate with disease severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/67\">",
"     67",
"    </a>",
"    ]. Toxin A causes inflammation leading to intestinal fluid secretion, mucosal injury, and inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. Mediators in these pathways include arachidonic acid metabolites, substance P, tumor necrosis factor, and interleukin (IL)-8, IL-6, and IL-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/70-73\">",
"     70-73",
"    </a>",
"    ]. Toxin A directly activates neutrophils, and both toxin A and B can promote neutrophil chemotaxis to localize in pseudomembranes and the underlying intestinal mucosal layer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Toxin B is essential for the virulence of C. difficile, and is approximately 10 times more potent than toxin A on a molar basis for mediating colonic mucosal damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/64,76,77\">",
"     64,76,77",
"    </a>",
"    ]. Thus, strains lacking toxin A can be as virulent as strains with both toxins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/75,76,78-80\">",
"     75,76,78-80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A minority of C. difficile strains are non-toxigenic and do not produce toxins in vivo or in vitro; these strains can colonize the gastrointestinal tract and grow normally in culture media but are not pathogenic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HYPERVIRULENT STRAIN: NAP1/BI/027",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hypervirulent strain,",
"    <span class=\"nowrap\">",
"     NAP1/BI/027,",
"    </span>",
"    has been implicated as the responsible pathogen in selected Clostridium difficile outbreaks since the early 2000s. The name of this strain reflects its characteristics demonstrated by different methods for strain typing: pulsed-field gel electrophoresis (NAP1), restriction endonuclease analysis (BI), and polymerase chain reaction (027). All of these designations refer to the same strain, known as strain",
"    <span class=\"nowrap\">",
"     NAP1/BI/027.",
"    </span>",
"    Interestingly, NAP1 may not be hypervirulent in a nonepidemic setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Five characteristics of this strain contribute to the clinical and epidemiologic observations. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The epidemic strain produces binary toxin, an additional toxin that is not present in other C. difficile strains [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/43,83,84\">",
"       43,83,84",
"      </a>",
"      ]. Binary toxin is related to the iota-toxin found in Clostridium perfringens; its role in C. difficile pathogenesis is not fully understood [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/85,86\">",
"       85,86",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The epidemic strain produces substantially larger quantities of toxins A and B in vitro than other C. difficile strains [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The epidemic strain is toxinotype III; most other C. difficile strains are toxinotype 0 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/10,87\">",
"       10,87",
"      </a>",
"      ]. Toxinotyping is based on analysis of the pathogenic locus (PaLoc) of the C. difficile genome; this is the region that includes the genes for toxin A (tcdA), toxin B (tcdB), and neighboring regulatory genes.",
"     </li>",
"     <li>",
"      The epidemic strain has a partial deletion of tcdC, a gene in the pathogenicity locus (PaLoc) that is responsible for downregulation of toxin production [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/10,88\">",
"       10,88",
"      </a>",
"      ]. This may contribute to the enhanced capability for production of toxins A and B.",
"     </li>",
"     <li>",
"      The epidemic strain is resistant to fluoroquinolones in vitro; this was an infrequent observation in C. difficile strains prior to 2001 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/5,7,9,10\">",
"       5,7,9,10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lower clinical cure rates and increased recurrence rates have been observed among patients infected with the epidemic BI strain compared with patients infected with non-BI strains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. However, the hypervirulent strain's genomic makeup and altered toxin-producing capabilities do not fully explain the increasing frequency and severity of disease, since historic isolates of",
"    <span class=\"nowrap\">",
"     NAP1/BI/027",
"    </span>",
"    possessing binary toxin genes and tcdC deletions have also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/10\">",
"     10",
"    </a>",
"    ]. However, a new observation is the increased resistance to fluoroquinolones; historic isolates of",
"    <span class=\"nowrap\">",
"     NAP1/BI/027",
"    </span>",
"    were not as resistant to fluoroquinolones as the contemporary ones. A selective advantage afforded by increased resistance to a particular antimicrobial has also been observed previously; the highly",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    -resistant \"J strain\" was associated with epidemics in the late 1980s and early 1990s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathogen and host factors probably play important roles in the evolving epidemiology of Clostridium difficile. Toxin production and other microbiologic factors are outlined in detail above (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Microbiology'",
"    </a>",
"    above). Host factors include toxin A antibody production, interleukin (IL)-8 levels, and intestinal toxin receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/91-95\">",
"     91-95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum antitoxin antibodies are the best described host factor in C. difficile pathogenesis. Asymptomatic carriers demonstrate higher serum levels of IgG antibody against toxin A than patients who develop clinical C. difficile infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/91-94\">",
"     91-94",
"    </a>",
"    ]. In a prospective study of 271 hospitalized patients, patients with low or undetectable levels of antibody against C. difficile toxin A were significantly more likely to develop diarrhea than those with detectable antibody against toxin A (odds ratio 48; 95% CI 3.4 to 678) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/24,91\">",
"     24,91",
"    </a>",
"    ]. It is important to note that these observations were made on the basis of measurements of serologic response to infection in the absence of baseline antibody levels prior to infection. Mounting a serum antibody response to toxin A during an initial episode of C. difficile-associated diarrhea (CDAD) was associated with relative protection against recurrent CDAD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/92,96\">",
"     92,96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colonization with nontoxigenic strains also affords protection. This observation suggests that the initial colonizing strain may occupy a microbial niche in the large intestine that is protective against superinfection with a new C. difficile strain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/26,97\">",
"     26,97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elevated serum IL-8 levels appear to correlate with an impaired humoral immune response to C. difficile toxin A and enhanced susceptibility to CDAD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/95,98\">",
"     95,98",
"    </a>",
"    ]. This was suggested in a report of 125 hospitalized patients (42 with C. difficile disease, 42 with C. difficile negative diarrhea, and 41 without diarrhea) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/95\">",
"     95",
"    </a>",
"    ]. The frequency of an IL-8 allele with a single nucleotide polymorphism (genotype AA, responsible for increased IL-8 production) was significantly associated with development of C. difficile diarrhea in comparison to the two control groups (39 versus 16 and 17 percent, respectively). CDAD patients also had higher median fecal IL-8 levels compared with control patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The absence of intestinal receptors for C. difficile toxins may be protective against C. difficile infection. Although this observation has been made in an animal neonate model, it may also play a role in the pathogenesis of C. difficile in human newborns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/99\">",
"     99",
"    </a>",
"    ]. These individuals have a relatively high asymptomatic C. difficile carriage rate (up to 50 percent) in the setting of elevated C. difficile toxin stool titers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/99-101\">",
"     99-101",
"    </a>",
"    ]. Serum and stool immunoglobulin levels subsequently develop by two years of age in about 60 percent of healthy children, and protective antibody is preserved through adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36137/abstract/102,103\">",
"     102,103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/52/19267?source=see_link\">",
"       \"Patient information: Antibiotic-associated diarrhea caused by Clostridium difficile (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Colonization of Clostridium difficile occurs via the fecal-oral route and sometimes, but not always, requires disruption of normal intestinal flora by antimicrobial therapy. The antibiotics most frequently implicated in predisposition to C. difficile-associated diarrhea (CDAD) include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      , penicillins, cephalosporins, and fluoroquinolones. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dramatic increases in the frequency, severity, and refractoriness of C. difficile in multiple outbreaks around the world have been attributed to the hypervirulent strain",
"      <span class=\"nowrap\">",
"       NAP1/BI/027.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Hypervirulent strain: NAP1/BI/027'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      C. difficile produces two toxins that bind to receptors on intestinal epithelial cells, leading to inflammation and diarrhea. Individuals with low or undetectable levels of antibody against C. difficile toxin A are more likely to develop diarrhea than those with detectable antibody against toxin A. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Microbiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Careful adherence to infection control policies is critical to the control of C. difficile. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19658?source=see_link\">",
"       \"General principles of infection control\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/1\">",
"      Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/2\">",
"      Bartlett JG, Moon N, Chang TW, et al. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978; 75:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/3\">",
"      Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999; 341:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/4\">",
"      Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010; 50:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/5\">",
"      P&eacute;pin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/6\">",
"      He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013; 45:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/7\">",
"      Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/8\">",
"      P&eacute;pin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/9\">",
"      P&eacute;pin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/10\">",
"      McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/11\">",
"      Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005; 26:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/12\">",
"      Goorhuis A, Van der Kooi T, Vaessen N, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007; 45:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/13\">",
"      Kuijper EJ, Coignard B, T&uuml;ll P, et al. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 Suppl 6:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/14\">",
"      Hall AJ, Curns AT, McDonald LC, et al. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/15\">",
"      Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/16\">",
"      Belmares J, Johnson S, Parada JP, et al. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. Clin Infect Dis 2009; 49:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/17\">",
"      Walk ST, Micic D, Jain R, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012; 55:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/18\">",
"      Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/19\">",
"      McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/20\">",
"      Gravel D, Miller M, Simor A, et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/21\">",
"      McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/22\">",
"      Riggs MM, Sethi AK, Zabarsky TF, et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007; 45:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/23\">",
"      Gerding DN, Johnson S, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/24\">",
"      Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/25\">",
"      Samore MH, Venkataraman L, DeGirolami PC, et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/26\">",
"      Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007; 45:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/27\">",
"      Shim JK, Johnson S, Samore MH, et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998; 351:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/28\">",
"      Hirschhorn LR, Trnka Y, Onderdonk A, et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994; 169:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/29\">",
"      Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003; 51:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/30\">",
"      Wistr&ouml;m J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/31\">",
"      Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/32\">",
"      Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/33\">",
"      Bliss DZ, Johnson S, Savik K, et al. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998; 129:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/34\">",
"      Kamthan AG, Bruckner HW, Hirschman SZ, Agus SG. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med 1992; 152:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/35\">",
"      Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993; 17:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/36\">",
"      Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/37\">",
"      Johnson S, Clabots CR, Linn FV, et al. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990; 336:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/38\">",
"      Gurwith MJ, Rabin HR, Love K. Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. J Infect Dis 1977; 135 Suppl:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/39\">",
"      Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974; 81:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/40\">",
"      Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/41\">",
"      Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998; 40:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/42\">",
"      Stevens V, Dumyati G, Fine LS, et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011; 53:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/43\">",
"      Geric B, Rupnik M, Gerding DN, et al. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 2004; 53:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/44\">",
"      Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012; 67:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/45\">",
"      Carignan A, Allard C, P&eacute;pin J, et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46:1838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/46\">",
"      Doernberg SB, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis 2012; 55:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/47\">",
"      Falsen E, Kaijser B, Nehls L, et al. Clostridium difficile in relation to enteric bacterial pathogens. J Clin Microbiol 1980; 12:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/48\">",
"      Campbell RR, Beere D, Wilcock GK, Brown EM. Clostridium difficile in acute and long-stay elderly patients. Age Ageing 1988; 17:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/49\">",
"      Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294:2989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/50\">",
"      Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 2006; 175:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/51\">",
"      Linsky A, Gupta K, Lawler EV, et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010; 170:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/52\">",
"      Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010; 170:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/53\">",
"      Morrison RH, Hall NS, Said M, et al. Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 2011; 53:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/54\">",
"      Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107:1011.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/Drugs/DrugSafety/ucm290510.htm (Accessed on February 14, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/56\">",
"      Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012; 107:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/57\">",
"      Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/58\">",
"      Hecker MT, Riggs MM, Hoyen CK, et al. Recurrent infection with epidemic Clostridium difficile in a peripartum woman whose infant was asymptomatically colonized with the same strain. Clin Infect Dis 2008; 46:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/59\">",
"      Gould LH, Limbago B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis 2010; 51:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/60\">",
"      Hall, IC, O'Toole, E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe Bacillus difficilis. Am J Dis Child 1935; 49:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/61\">",
"      George RH, Symonds JM, Dimock F, et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1978; 1:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/62\">",
"      Price SB, Phelps CJ, Wilkins TD, Johnson JL. Cloning of the carbohydrate-binding portion of the toxin a gene of Clostridium difficile. Curr Microbiol 1987; 16:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/63\">",
"      Just I, Selzer J, Wilm M, et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995; 375:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/64\">",
"      Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995; 95:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/65\">",
"      Brito GA, Sullivan GW, Ciesla WP Jr, et al. Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis 2002; 185:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/66\">",
"      Hecht G, Koutsouris A, Pothoulakis C, et al. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992; 102:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/67\">",
"      Akerlund T, Svenungsson B, Lagergren A, Burman LG. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006; 44:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/68\">",
"      Lima AA, Innes DJ Jr, Chadee K, et al. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine. Lab Invest 1989; 61:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/69\">",
"      Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 1996; 60:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/70\">",
"      Castagliuolo I, Riegler M, Pasha A, et al. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest 1998; 101:1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/71\">",
"      Mahida YR, Makh S, Hyde S, et al. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 1996; 38:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/72\">",
"      Melo Filho AA, Souza MH, Lyerly DM, et al. Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophages. Toxicon 1997; 35:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/73\">",
"      Warny M, Keates AC, Keates S, et al. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest 2000; 105:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/74\">",
"      Pothoulakis C, Sullivan R, Melnick DA, et al. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest 1988; 81:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/75\">",
"      Souza MH, Melo-Filho AA, Rocha MF, et al. The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B. Immunology 1997; 91:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/76\">",
"      Lyras D, O'Connor JR, Howarth PM, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/77\">",
"      Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38:2706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/78\">",
"      Moncrief JS, Zheng L, Neville LM, Lyerly DM. Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR. J Clin Microbiol 2000; 38:3072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/79\">",
"      Limaye AP, Turgeon DK, Cookson BT, Fritsche TR. Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. J Clin Microbiol 2000; 38:1696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/80\">",
"      Kuehne SA, Cartman ST, Heap JT, et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/81\">",
"      McFarland LV, Elmer GW, Stamm WE, Mulligan ME. Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infect Immun 1991; 59:2456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/82\">",
"      Cloud J, Noddin L, Pressman A, et al. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 2009; 7:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/83\">",
"      Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002; 40:3470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/84\">",
"      Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56:2299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/85\">",
"      McEllistrem MC, Carman RJ, Gerding DN, et al. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 2005; 40:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/86\">",
"      Barbut F, Decr&eacute; D, Lalande V, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005; 54:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/87\">",
"      Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/88\">",
"      Rupnik M, Avesani V, Janc M, et al. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 1998; 36:2240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/89\">",
"      Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012; 55:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/90\">",
"      Marsh JW, Arora R, Schlackman JL, et al. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012; 50:4078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/91\">",
"      Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/92\">",
"      Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/93\">",
"      Leung DY, Kelly CP, Boguniewicz M, et al. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991; 118:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/94\">",
"      Warny M, Vaerman JP, Avesani V, Delm&eacute;e M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994; 62:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/95\">",
"      Jiang ZD, Garey KW, Price M, et al. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol 2007; 5:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/96\">",
"      Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996; 8:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/97\">",
"      Sambol SP, Merrigan MM, Tang JK, et al. Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 2002; 186:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/98\">",
"      Jiang ZD, DuPont HL, Garey K, et al. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol 2006; 101:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/99\">",
"      Eglow R, Pothoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest 1992; 90:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/100\">",
"      Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/101\">",
"      M&aring;rdh PA, Helin I, Colleen I, et al. Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea. Acta Paediatr Scand 1982; 71:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/102\">",
"      Viscidi R, Laughon BE, Yolken R, et al. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983; 148:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36137/abstract/103\">",
"      Kelly CP, Pothoulakis C, Orellana J, LaMont JT. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 1992; 102:35.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2696 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-59E8FFCE15-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36137=[""].join("\n");
var outline_f35_18_36137=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Nosocomial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Advanced age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Gastric acid suppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Community-associated infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HYPERVIRULENT STRAIN: NAP1/BI/027",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2696\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2696|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/13/1245\" title=\"figure 1\">",
"      Pathogenesis C diff diarrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2696|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/24/39310\" title=\"picture 1\">",
"      Clostridium difficile",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2696|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/35/25147\" title=\"table 1\">",
"      Antibiotics C diff diarrhea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=related_link\">",
"      Clostridium difficile in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/29/20954?source=related_link\">",
"      Clostridium difficile in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/52/19267?source=related_link\">",
"      Patient information: Antibiotic-associated diarrhea caused by Clostridium difficile (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12184?source=related_link\">",
"      Prevention and control of Clostridium difficile in hospital and institutional settings",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_18_36138="Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation";
var content_f35_18_36138=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Steven A Curley, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Keith E Stuart, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Jonathan M Schwartz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Robert L Carithers, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/18/36138/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/18/36138/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatocellular carcinoma (HCC) is an aggressive tumor that frequently occurs in the setting of cirrhosis. The patient's hepatic reserve often dictates therapeutic options (",
"    <a class=\"graphic graphic_table graphicRef56735 \" href=\"mobipreview.htm?32/62/33771\">",
"     table 1",
"    </a>",
"    ). Treatment options are divided into surgical therapies (ie, resection, cryoablation, and orthotopic liver transplantation [OLT]), and nonsurgical therapies (ie, percutaneous ethanol injection [PEI], radiofrequency ablation [RFA], transarterial chemoembolization [TACE], radiation therapy [RT], and systemic therapy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Treatment algorithms",
"    </span>",
"    &nbsp;&mdash;&nbsp;A general approach to the treatment of HCC is shown in the figure (",
"    <a class=\"graphic graphic_algorithm graphicRef57014 \" href=\"mobipreview.htm?40/37/41567\">",
"     algorithm 1",
"    </a>",
"    ). An alternative treatment algorithm is used by the Barcelona group (",
"    <a class=\"graphic graphic_algorithm graphicRef69566 \" href=\"mobipreview.htm?11/36/11855\">",
"     algorithm 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/1\">",
"     1",
"    </a>",
"    ]. However, attempts to generate algorithmic approaches to the treatment of HCC are difficult since new treatments and indications for various treatments are evolving rapidly. Furthermore, therapeutic approaches tend to vary based upon the available expertise, as well as variability in the criteria for hepatic resection and orthotopic liver transplantation. These issues and a general approach to treatment of HCC are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43063?source=see_link\">",
"     \"Overview of treatment approaches for hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H457345914\">",
"    <span class=\"h2\">",
"     Importance of comprehensive multidisciplinary care",
"    </span>",
"    &nbsp;&mdash;&nbsp;A majority of patients with HCC have underlying liver disease, which may be related to infection with hepatitis B virus (HBV)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hepatitis C virus (HCV). Furthermore, patients who undergo any of these forms of therapy are at high risk for recurrent disease and of progression to liver failure. It is important that patients with more advanced liver disease have proper monitoring and assessment of their underlying liver disease, which may have a major impact on longer term survival. Comprehensive care of patients with cirrhosis includes antiviral therapy for HBV and HCV, immunization against hepatitis A and HBV (if indicated), and endoscopic screening and surveillance for varices. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25194?source=see_link\">",
"     \"Epidemiology and etiologic associations of hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/59/17337?source=see_link\">",
"     \"Overview of the complications, prognosis, and management of cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will cover RFA, PEI, thermal methods of tumor ablation, and cryoablation for HCC. Other nonsurgical therapies for HCC (transarterial embolization, RT, and radioembolization) are discussed elsewhere, as are surgical resection, transplantation, and systemic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/6/14442?source=see_link\">",
"     \"Surgical management of potentially resectable hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link\">",
"     \"Liver transplantation for hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/61/39898?source=see_link\">",
"     \"Systemic treatment for advanced hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ASSESSING RESPONSE TO LOCOREGIONAL THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard methods to assess treatment response (eg, unidimensional RECIST criteria (",
"    <a class=\"graphic graphic_table graphicRef74693 \" href=\"mobipreview.htm?41/48/42764\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/2\">",
"     2",
"    </a>",
"    ], bidimensional perpendicular measurement using WHO criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/3\">",
"     3",
"    </a>",
"    ]) involve measurement of tumor dimensions before and after treatment. Methods such as these disregard the extent of necrosis, which is the end result of locoregional ablative therapies.",
"   </p>",
"   <p>",
"    Typically the efficacy of percutaneous ablation therapy is assessed by dynamic CT or MRI one month after therapy. Although not entirely reliable, the absence of contrast uptake within the tumor reflects tumor necrosis, while the persistence of contrast uptake indicates persistent disease. Recurrence of tumor in the treated area (or elsewhere) is signaled by the reappearance of vascular enhancement.",
"   </p>",
"   <p>",
"    Although not used widely, guidelines from the European Association for Study of the Liver (EASL) suggest that estimated reduction in viable tumor burden using dynamic imaging techniques be incorporated into definitions for response in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete response (CR) &mdash; Absence of enhanced tumor areas, reflecting complete necrosis",
"     </li>",
"     <li>",
"      Partial response (PR) &mdash; A &gt;50 percent decrease in enhanced areas, reflecting partial tissue necrosis",
"     </li>",
"     <li>",
"      Progressive disease (PD) &mdash; An increase &gt;25 percent in the size of &ge;1 measurable lesion or appearance of a new lesion",
"     </li>",
"     <li>",
"      Stable disease &mdash; Any tumor response between PR and PD",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Others have proposed a modification in RECIST for HCC for use in formal response assessment, which parallels the definitions of conventional RECIST, and measures the amount of residual viable tumor tissue by summing the length of the remnant viable parts (",
"    <a class=\"graphic graphic_table graphicRef58792 \" href=\"mobipreview.htm?27/46/28396\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is little inter-method agreement between \"response rates\" as assessed by EASL and standard",
"    <span class=\"nowrap\">",
"     RECIST/WHO",
"    </span>",
"    criteria. However, extensive necrosis as detected by any method represents a favorable independent prognostic factor for survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the subset of patients with an elevated alpha-fetoprotein (AFP), this marker can be useful to follow response and provide an early screening test for progression by imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Unfortunately, AFP levels are not elevated in up to 40 percent of patients with HCC &lt;2 cm in diameter and in 28 percent of those with tumors 2 to 5 cm. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\", section on 'Alpha-fetoprotein'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     RADIOFREQUENCY ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) relies on a needle electrode to deliver a high frequency alternating current from the tip of an electrode into the tissue surrounding that electrode. As the ions within the tissue attempt to follow the change in the direction of the alternating current, their movement results in frictional heating of the tissue. As the temperature within the tissue becomes elevated beyond 60&ordm;C, cells begin to die, resulting in a region of necrosis surrounding the electrode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Patient selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA has been used in patients who do not meet resectability criteria for HCC and yet are candidates for a liver-directed procedure based upon the presence of liver-only disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/6/14442?source=see_link\">",
"     \"Surgical management of potentially resectable hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some clinicians restrict RFA to cirrhotic patients of Child-Pugh class A or B severity only (",
"    <a class=\"graphic graphic_table graphicRef78401 \" href=\"mobipreview.htm?8/21/8540\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/12\">",
"     12",
"    </a>",
"    ]. Although there is no absolute tumor size beyond which RFA should not be considered, the best outcomes are in patients with a single tumor size &lt;4 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/12\">",
"     12",
"    </a>",
"    ]. Percutaneous RFA is also an effective means of treating recurrent HCC in the liver following partial hepatectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some have been reluctant to perform RFA in patients with subcapsular tumors, since needle-track seeding was observed in 4 of 32 patients in one series, all of whom had tumors &le;1 cm from the hepatic capsule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/15\">",
"     15",
"    </a>",
"    ]. However, a cooled tip electrode was used in these patients, which may have permitted viable tumor cells to survive the procedure. At least some published data supports the safety and efficacy of this procedure in appropriately selected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Furthermore, one of the authors (SC) has not observed any case of needle track seeding in over 200 patients with HCC treated with a standard RFA electrode.",
"   </p>",
"   <p>",
"    RFA may be avoided for treatment of lesions that are located in the dome or along the inferior liver edge for fear of diaphragmatic injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/18\">",
"     18",
"    </a>",
"    ] or intestinal perforation. However, with attention to technique (such as insulating adjacent bowel from the thermal process, an approach that can be accomplished using a laparoscopic or open laparotomy approach), these lesions can be successfully treated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/12\">",
"     12",
"    </a>",
"    ]. Tumors at the inferior edge of the liver should not be treated percutaneously if the stomach, duodenum, or transverse colon lies in close proximity to the tumor. (See",
"    <a class=\"local\" href=\"#H950876102\">",
"     'Results'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H17\">",
"     'Adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;A needle electrode is advanced into the tumor via a percutaneous, laparoscopic, or open (laparotomy) route. There are no randomized trials and no consensus as to the best approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/12,19\">",
"     12,19",
"    </a>",
"    ]. However, a meta-analysis of uncontrolled data on 5224 tumors treated by RFA concluded that treatment approach was a significant independent factor for local control, with the open approach providing superior local control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/20\">",
"     20",
"    </a>",
"    ]. However, this analysis was limited by the various types of electrodes and techniques used in the studies. Others conclude that the percutaneous approach is preferred for smaller (&le;3 cm) tumors that are accessible percutaneously and appropriately situated because of similar tumor control and less morbidity as compared to the open approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    At least in the United States, most patients are treated by interventional radiologists using the percutaneous approach.",
"   </p>",
"   <p>",
"    Several types of needle electrodes have been developed for the clinical application of RFA. The device we have used most frequently is a 14-gauge, 15 to 25 cm long, insulated cannula containing 10 individual hook-shaped electrode arms or tines. Upon deployment, the array of tines extends out to a diameter of 2.0, 3.0, 3.5, or 4.0 cm. Tumors &lt;3 cm in greatest diameter can be ablated with the placement of a needle electrode with an array diameter of 3.5 cm when the electrode is positioned in the center of the tumor.",
"   </p>",
"   <p>",
"    Using US to guide placement, the needle electrode is advanced into the area of the tumor to be treated. Once the tines have been extended or deployed into the tissue, the needle electrode is attached to a radiofrequency generator and treatment is performed.",
"   </p>",
"   <p>",
"    RFA can predictably produce an ablation area of 3 cm at a single application. Tumors &gt;3 cm require more than one deployment of the needle electrode. In one series of 1000 RFA procedures (2140 nodules) in 664 patients, tumor size was 2, 2.1 to 5, and &gt;5 cm in 200, 424, and 40 patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/14\">",
"     14",
"    </a>",
"    ]. All nodules were ablated completely, and the mean number of electrode insertions according to tumor size was: 1.5 times for nodules &lt;2 cm, and 2.3, 4.2, and 11.7 times for nodules 2.1 to 3, 3.1 to 5, and &gt;5 cm, respectively.",
"   </p>",
"   <p>",
"    Typically, the array is first placed at the most posterior interface between the tumor and nonmalignant liver parenchyma and then repositioned for repeat deployments anteriorly at 2.0 to 2.5 cm intervals within the tissue. In order to mimic a surgical margin in these unresectable tumors, the needle electrode is used to produce a thermal lesion that incorporates not only the tumor but also nondiseased liver parenchyma in a zone 1 cm wide surrounding the tumor.",
"   </p>",
"   <p>",
"    It is difficult to reliably destroy tumors &ge;5 to 6 cm in diameter with current RFA devices. Newer equipment that can produce larger zones of ablation is currently under investigation. One small series suggests a possible benefit from adding a single dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/13/10458?source=see_link\">",
"     pegylated liposomal doxorubicin",
"    </a>",
"    (20 mg IV) 24 hours prior to planned RFA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/22\">",
"     22",
"    </a>",
"    ]. When five patients randomly assigned to receive",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    were compared to five who underwent RFA only, the zone of coagulation necrosis at the RFA site was 3.4-fold larger. Clinical outcomes were not reported.",
"   </p>",
"   <p>",
"    Others suggest benefit for the addition of transarterial chemoembolization prior to RFA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link&amp;anchor=H1248650293#H1248650293\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\", section on 'Transarterial embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following treatment, response can be assessed using dynamic imaging with contrast-enhanced CT or MRI. In the subset of patients with an elevated alpha-fetoprotein (AFP), this marker can be useful to follow response and provide an early screening test for progression by imaging. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Assessing response to locoregional therapies'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link&amp;anchor=H361320196#H361320196\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\", section on 'Assessing response to locoregional therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete response rates following RFA are 80 to 90 percent for tumors &lt;3 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/26-30\">",
"     26-30",
"    </a>",
"    ]. Complete necrosis rates are 50 to 70 percent for lesions between 3 and 5 cm and lower for larger lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/9,14,26,27,31,32\">",
"     9,14,26,27,31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to size, local efficacy is also affected by proximity of the lesion to large blood vessels (&ge;3 mm). In a histologic study of explanted livers from 24 patients with HCC undergoing RFA prior to liver transplantation, the rates of complete necrosis for tumors with nonperivascular and perivascular locations were 88 and 47 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/33\">",
"     33",
"    </a>",
"    ]. IT is speculated that blood flow in these large abutting vessels carries heat away from the lesions, known as the &ldquo;heat sink&rdquo; phenomenon.",
"   </p>",
"   <p>",
"    Posttherapy local recurrence rates range between 0 and 26 percent, but average 3 to 6 percent. Local recurrence rates are generally lower than are seen with PEI. (See",
"    <a class=\"local\" href=\"#H950876102\">",
"     'Results'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Long-term outcomes are available from several large retrospective series and randomized trials comparing RFA versus PEI:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reported three- and five-year survival rates following RFA for patients fulfilling the Milan transplantation criteria (single tumor &lt;5 cm, or three or fewer tumors, each &le;3 cm) range from 70 to 91, and 48 to 77 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/34-36\">",
"       34-36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      As expected, long-term outcomes are better in patients with smaller lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/14,37,38\">",
"       14,37,38",
"      </a>",
"      ]. In one series of 302 patients, the three-year survival rates for lesions &gt;5 cm, 2.1 to 5 cm, and &le;2 cm were 59, 74, and 91 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Retreatment may be feasible and result in long-term disease control in selected patients with a localized intrahepatic recurrence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/39\">",
"       39",
"      </a>",
"      ]. However, local recurrences are uncommon in the hands of experienced clinicians treating small tumors, and distant recurrences predominate, especially if patients are followed over a long period of time. This was shown in an analysis of five and 10-year survival following RFA in a Japanese series of 1170 patients with HCC, the majority of whom fulfilled the Milan criteria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/40\">",
"       40",
"      </a>",
"      ]. Five and 10-year survival rates were 60 and 27 percent, respectively. While the five and 10-year local progression rates were only 3 percent each, the distant recurrence rates were 75 and 81 percent, respectively.",
"      <br/>",
"      <br/>",
"      Local recurrence rates are variable, ranging from 2 to 36 percent in other studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/9,41-44\">",
"       9,41-44",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876927\">",
"    <span class=\"h2\">",
"     RFA versus PEI",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least two meta-analyses have demonstrated the superiority of RFA over percutaneous ethanol ablation (PEI) in terms of survival, cancer-free survival, and local recurrence. (See",
"    <a class=\"local\" href=\"#H950877120\">",
"     'Versus RFA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876859\">",
"    <span class=\"h2\">",
"     RFA versus surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of RFA relative to surgical resection for potentially resectable HCC has been addressed in three randomized trials from China [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/45-47\">",
"     45-47",
"    </a>",
"    ] and a meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/48\">",
"     48",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest randomized trial, 230 patients with HCC meeting the Milan transplantation criteria (single tumor &lt;5 cm, or three or fewer tumors, each &le;3 cm) who were suitable candidates for either therapy were randomly assigned to RFA or surgical resection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/47\">",
"       47",
"      </a>",
"      ]. Overall survival was significantly higher in the resection group (at five-years, 76 versus 55 percent), as was recurrence-free survival (51 versus 29 percent). Overall recurrence rates were significantly lower following resection (42 versus 63 percent).",
"     </li>",
"     <li>",
"      In contrast, benefit for surgery could not be shown in two other trials. In the first, 180 patients with a solitary HCC &le;5 cm were randomly assigned to partial hepatectomy or percutaneous local ablative therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/45\">",
"       45",
"      </a>",
"      ]. Only 71 of the 90 patients randomized to local ablation actually received it (all by RFA, with or without ethanol or TACE); the remainder refused the treatment allocation and underwent surgery. When analyzed according to intention to treat, with median follow-up 28 to 29 months, overall and disease-free survival rates were comparable in the two groups at one, two, three, and four years. The results did not change when the analysis was restricted to the 71 patients who actually underwent RFA and the 90 who were randomly assigned to surgery. In the subset of patients with larger tumors (3.1 to 5 cm), the three-year disease-free survival rates were higher for surgery (65 versus 45 percent), but this large difference did not reach statistical significance based upon the limited sample size.",
"      <br/>",
"      <br/>",
"      The second trial randomly assigned 105 patients with a single HCC nodule &le;5 cm or three or fewer lesions, all &le;3 cm, to surgical resection or percutaneous thermal ablation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/46\">",
"       46",
"      </a>",
"      ]. There were no local recurrences in either group, and three-year overall survival rates were also similar (86 versus 87 percent for surgery and RFA, respectively). Three year disease-free survival rates were higher in the surgery group, but the difference was not statistically significant (82 versus 51 percent).",
"     </li>",
"     <li>",
"      A meta-analysis, which included one of the randomized trials [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/45\">",
"       45",
"      </a>",
"      ] and nine nonrandomized comparative studies (totaling 1411 patients, 744 treated with RFA, 667 undergoing surgery), concluded that local recurrence rates were significantly lower, and three-year overall survival was significantly better in surgically treated patients (odds ratio [OR] for death 0.56, 95% CI 0.44-0.71) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/48\">",
"       48",
"      </a>",
"      ]. However, in a subanalysis of three nonrandomized trials, there was no survival benefit for surgery for tumors &le;3 cm. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these data, most clinicians consider that surgery is preferable, if it is feasible, even for small tumors. Long-term survival rates of 40 percent or higher can be achieved with limited hepatic resections. In carefully selected patients having no vascular invasion by tumor, solitary lesions without intrahepatic metastasis, tumor diameter &le;5 cm, and a negative surgical margin of &gt;1 cm, up to 78 percent five-year survival rates following resection have been reported. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21978?source=see_link&amp;anchor=H969401849#H969401849\">",
"     \"Management of potentially resectable hepatocellular carcinoma: Prognosis, role of neoadjuvant and adjuvant therapy, and posttreatment surveillance\", section on 'Long-term outcomes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/6/14442?source=see_link\">",
"     \"Surgical management of potentially resectable hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950877323\">",
"    <span class=\"h2\">",
"     RFA as bridging or downstaging therapy in transplant candidates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of RFA in patients who have an anticipated long wait time to reduce the number of dropouts from the transplant list because of tumor progression (referred to as &ldquo;bridging&rdquo; therapy) or in an attempt to downstage an individual patient whose HCC is beyond the usual transplantation criteria (referred to as neoadjuvant or &ldquo;downstaging&rdquo; therapy) is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link&amp;anchor=H10#H10\">",
"     \"Liver transplantation for hepatocellular carcinoma\", section on 'Bridging therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link&amp;anchor=H24#H24\">",
"     \"Liver transplantation for hepatocellular carcinoma\", section on 'Downstaging through neoadjuvant locoregional therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104900276\">",
"    <span class=\"h2\">",
"     RFA plus TACE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of the blood supply to an HCC is derived from the hepatic artery rather than the portal vein. This has led to the development of techniques designed to eliminate the tumor's blood supply by particle embolization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    directly infuse cytotoxic chemotherapy into the branch of the hepatic artery that feeds the tumor. The majority of published experience is with transarterial chemoembolization (TACE), in which transarterial embolization is combined with the prior injection into the hepatic artery of chemotherapeutic agents, without or with lipiodol. TACE is usually applied to patients with large unresectable or multiple HCCs that are not suitable for resection or local ablation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link&amp;anchor=H1248650293#H1248650293\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\", section on 'Transarterial embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Combining RFA and TACE can theoretically overcome the limitations of each when used alone. While some studies have suggested benefit for combining TACE with RFA versus RFA alone, the data are conflicting. A meta-analysis of eight randomized controlled trials and 11 retrospective cohort studies concluded that combination TACE plus RFA was associated with a higher survival rate than RFA alone, but the quality of the evidence was judged to be low and the analysis did not consider the toxicity of combined therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/49\">",
"     49",
"    </a>",
"    ]. A later randomized trial comparing RFA with and without TACE in 189 patients with a single HCC &lt;7 cm found common complications in both groups (fever, pain, vomiting, ascites, pleural effusion, and skin burn) and no significant differences in the rate or severity of treatment-related toxicity between the two groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our view, additional randomized trials with larger sample sizes and more complete data capture are needed before it can be concluded that there is benefit for a combined approach over RFA alone. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although RFA is relatively well tolerated, severe and potentially fatal complications can arise. Major complications develop in 2.2 to 11 percent, and the procedural mortality rate is 0.3 to 0.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/51-53\">",
"     51-53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, in one series of 312 patients undergoing 350 procedures (226 percutaneous and the remainder intraoperative), there were five attributable deaths (one each from liver failure and colon perforation, three from portal vein thrombosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/51\">",
"     51",
"    </a>",
"    ]. Portal vein thrombosis was significantly more common in cirrhotic",
"    <span class=\"nowrap\">",
"     (2/5)",
"    </span>",
"    compared to noncirrhotic livers",
"    <span class=\"nowrap\">",
"     (0/54)",
"    </span>",
"    after intraoperative RFA performed during a Pringle maneuver. The 37 nonfatal serious complications (incidence 11 percent) included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Liver abscess in seven, which developed in all three patients with a bilioenteric anastomosis compared with less than 2 percent of the others (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29526?source=see_link\">",
"       \"Pyogenic liver abscess\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pleural effusion and skin burns in five patients each",
"     </li>",
"     <li>",
"      Hypoxemia during treatment in four patients",
"     </li>",
"     <li>",
"      Pneumothorax in three patients",
"     </li>",
"     <li>",
"      Subcapsular hematoma in two patients",
"     </li>",
"     <li>",
"      Acute renal insufficiency, hemoperitoneum, and needle tract seeding in one patient each",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several of the more serious complications arise from placing the probe too close to the diaphragm or an intraabdominal organ, resulting in ablation of that organ, with the accompanying complications of perforation, diaphragmatic injury, or pulmonary damage. This can be avoided by using an open or laparoscopic approach to treatment, with or without the use of hydrodissection to push the gastrointestinal tract and diaphragm away from the tumor to allow for RFA. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Technique'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A self-limited postablation syndrome similar to that occurring after hepatic chemoembolization has been reported, with fever, malaise, chills, right upper quadrant pain, nausea, and elevated transaminase levels. Although not as well studied, the incidence seems to be lower after RFA (36 percent in one report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/54\">",
"     54",
"    </a>",
"    ]) than after chemoembolization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link&amp;anchor=H1248650293#H1248650293\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\", section on 'Transarterial embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA provides long-term local control in the majority of HCC patients, with the possibility of long-term, disease-free survival in selected patients with small tumors &le;2 cm. It is a safe and effective local treatment option, particularly for cirrhotic patients with small unresectable HCCs. At least two meta-analyses have demonstrated the superiority of RFA over PEI in terms of survival, cancer-free survival, and local recurrence. For patients who are reasonable surgical candidates, most clinicians consider that surgery is preferred over RFA, if it is feasible, even for small tumors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21978?source=see_link&amp;anchor=H969401849#H969401849\">",
"     \"Management of potentially resectable hepatocellular carcinoma: Prognosis, role of neoadjuvant and adjuvant therapy, and posttreatment surveillance\", section on 'Long-term outcomes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/6/14442?source=see_link\">",
"     \"Surgical management of potentially resectable hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876074\">",
"    <span class=\"h1\">",
"     PERCUTANEOUS ETHANOL INJECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injection of 95 percent ethanol directly into a tumor through a needle can induce local coagulation necrosis and a fibrous reaction, as well as thrombosis of tumor microvasculature and tissue ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. To achieve complete devitalization of the tumor, multiple treatment sessions are usually needed.",
"   </p>",
"   <p>",
"    Before the advent of RFA, PEI was the most widely accepted, minimally invasive method for treating HCC. Randomized trials and at least two meta-analyses have demonstrated superior results with RFA rather than PEI, and RFA has replaced PEI in most places (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Radiofrequency ablation'",
"    </a>",
"    above). However, PEI appears to be as effective as RFA for small tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/30,41,58\">",
"     30,41,58",
"    </a>",
"    ], costs less, and requires a minimal amount of equipment. It is still used to treat small HCCs in patients who are not suitable candidates for surgery, particularly in locations that are unsuitable for percutaneous RFA, such as adjacent to the gallbladder, hepatic hilum, or major vasculature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H950876927\">",
"     'RFA versus PEI'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876081\">",
"    <span class=\"h2\">",
"     Patient selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with RFA, PEI is often considered for patients with small HCCs who are not resection candidates due to poor hepatic reserve. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/6/14442?source=see_link\">",
"     \"Surgical management of potentially resectable hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Local response is closely related to tumor size. (See",
"    <a class=\"local\" href=\"#H950876102\">",
"     'Results'",
"    </a>",
"    below.) PEI is generally not recommended for tumors &gt;5 cm because of high local recurrence rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/60-63\">",
"     60-63",
"    </a>",
"    ]. However, local recurrence rates as high as 38 percent have been reported even for tumors up to 3 cm in diameter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/63\">",
"     63",
"    </a>",
"    ]. Because of these high recurrence rates, procedural pain, and the need for multiple treatments, we typically consider PEI only in patients with solitary tumors &lt;2 cm in diameter who lack the hepatic reserve to withstand resection and for whom RFA is not feasible. Lesions in the dome of the liver should not be considered for this approach.",
"   </p>",
"   <p>",
"    PEI may also be indicated in noncirrhotic patients with small tumors that cannot be resected for technical reasons. The use of this modality to treat patients with small HCCs who are awaiting OLT has not been well studied; however, at least in the United States, patients are more likely to be offered RFA or TACE. The subject of bridging therapy in patients awaiting transplant is addressed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=see_link&amp;anchor=H10#H10\">",
"     \"Liver transplantation for hepatocellular carcinoma\", section on 'Bridging therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876088\">",
"    <span class=\"h3\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candidates for PEI must have tumors whose volume is less than 30 percent of the total liver volume. PEI is contraindicated in patients with extrahepatic disease, portal vein thrombosis, Child-Pugh class C cirrhosis with a prothrombin time &gt;40 percent of normal, or a platelet count",
"    <span class=\"nowrap\">",
"     &gt;40,000/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/56,64\">",
"     56,64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876095\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;For smaller lesions, PEI can be performed as an outpatient procedure, with multiple separate injection sessions (eg, twice weekly injection of 1 to 8 mL ethanol for a total of 4 to 12 sessions). However, it is painful. Alternatively, an inpatient \"one shot\" technique with the patient under general anesthesia may be employed, in which approximately 60 to 150 mL of ethanol is delivered via multiple injections over 30 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4,61\">",
"     4,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conventionally, PEI is performed using a fine needle with an end hole, which does not ensure diffusion of ethanol to the entire tumor, especially if &ge;3 cm in size. A new device (Quadra-Fuse needle, REX Medical) has been developed, which is an 18 gauge puncture needle with three retractable prongs, each with four terminal side holes, that can be deployed up to 5 cm. These features facilitate even distribution of the ethanol within the tumor. Initial reports using this device are promising, with complete response rates of 67 and 84 percent in two small series of 12 and 20 patients with HCC, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. However, long-term outcomes have not yet been reported.",
"   </p>",
"   <p>",
"    Following PEI, patients are monitored with contrast-enhanced CT scans or MRI to determine if additional therapy is necessary. In the subset of patients with an elevated alpha-fetoprotein (AFP), this marker can be useful to follow response and provide an early screening test for progression by imaging. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Assessing response to locoregional therapies'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link&amp;anchor=H361320196#H361320196\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\", section on 'Assessing response to locoregional therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876102\">",
"    <span class=\"h2\">",
"     Results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local response is closely related to tumor size. A complete response can be obtained in 90 to 100 percent of tumors &lt;2 cm, in 70 to 80 percent of tumors &lt;3 cm, but only 50 to 60 percent for larger lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/55,67,68\">",
"     55,67,68",
"    </a>",
"    ]. Local recurrence rates range from 10 to 33 percent in tumors smaller than 3 cm and are 44 to 50 percent in larger tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/63,69-71\">",
"     63,69-71",
"    </a>",
"    ]. The poorer efficacy of PEI for larger tumors has been attributed to the presence of intratumoral septae, which limit the diffusion of the injected alcohol to the entire lesion. In addition, there may be difficulty visualizing the limits of the lesion on ultrasound due to &ldquo;bubbles&rdquo; formed during the alcohol injection.",
"   </p>",
"   <p>",
"    Several studies report long-term outcomes with PEI for small HCC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4,62,63,69,72\">",
"     4,62,63,69,72",
"    </a>",
"    ]. Five-year survival rate is significantly greater for tumors smaller than 3 cm as compared to those between 3 and 5 cm (40 to 54 versus 32 to 37 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4,72\">",
"     4,72",
"    </a>",
"    ]. One study of 4037 patients treated by PEI reported a five-year survival rate of 54 percent for a solitary HCC &lt;2 cm, while it was 39 percent for tumors between 2 and 5 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/62\">",
"     62",
"    </a>",
"    ]. Five-year survival rates as high as 78 percent are reported among patients with Child-Pugh A cirrhosis and a solitary HCC &le;2 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/69\">",
"     69",
"    </a>",
"    ]. In contrast, patients with solitary lesions 5 to 10 cm in diameter have three-year survival rates of only 42 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term results are worse in patients with underlying liver dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4,63,73\">",
"     4,63,73",
"    </a>",
"    ]. As an example, in a series of 112 patients, the three- and five-year survival rates for patients with Child-Pugh class A cirrhosis were 72 and 51 percent, respectively, while those with Child-Pugh class B cirrhosis had a 25 percent three-year survival, with no patients surviving five years or longer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950877120\">",
"    <span class=\"h3\">",
"     Versus RFA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple prospective randomized trials and two meta-analyses support the superiority of RFA over PEI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/30,41,58,74-79\">",
"     30,41,58,74-79",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Radiofrequency ablation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the larger meta-analysis of five randomized trials comparing RFA versus PEI, RFA was significantly superior in terms of overall survival (odds ratio [OR] 1.92, 95% CI 1.35 to 2.74), cancer-free survival (OR at three years 2.72, 95% CI 1.54-4.79), and rate of local recurrence (OR 0.29, 95% CI 0.18-0.47) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/79\">",
"     79",
"    </a>",
"    ]. All five trials enrolled patients with a variety of tumor size, up to and including 5 cm. The efficacy of RFA and PEI appears to be similar for tumors &le;2 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/30,41,58\">",
"     30,41,58",
"    </a>",
"    ]. Although RFA requires fewer treatment sessions (1.1 to 2.1 versus 4.9 to 6.5 sessions for PEI), its main drawback is higher cost and higher rate of adverse effects. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Adverse effects'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950877183\">",
"    <span class=\"h3\">",
"     Versus surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retrospective series suggest that for small solitary HCCs, PEI may produce survival rates that are similar to surgical resection. In one study of 63 patients with a solitary HCC &lt;4 cm found that tumor recurrence rates at two years were lower in those treated with surgery (45 versus 66 percent), but survival rates at one and four years were similar (81 and 44 percent for PEI, versus 86 and 34 percent for resection) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/80\">",
"     80",
"    </a>",
"    ]. In the only randomized trial to compare PEI and resection in 160 patients with a solitary HCC up to 5 cm in diameter, there was no significant difference in either disease-free or overall survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these results, most clinicians consider that surgery is preferable, if it is feasible, even for small tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950877211\">",
"    <span class=\"h3\">",
"     PEI plus other local therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;For small HCCs, the combination of PEI and TACE may provide better local control than PEI alone. In one trial, 52 patients with one to three HCCs measuring &lt;3 cm were randomly assigned to PEI alone or preceded by one course of TACE (using lipiodol plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    and Gelfoam) (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\"",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/81\">",
"     81",
"    </a>",
"    ]. The cumulative detection rates for residual disease were significantly lower at one and three years with TACE-PEI (3.7 and 19.3 percent, respectively) compared to PEI alone (34.2 and 39.3 percent, respectively). Nevertheless, the cumulative survival rates at one, three, and five years were not significantly different (100, 81, and 40 percent for TACE-PEI, and 91, 66, and 38 percent for PEI alone, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950876116\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;PEI is generally well tolerated; however, side effects such as localized pain and generalized peritoneal irritation due to ethanol leakage are common and may reduce patient compliance. Serious complications (intraperitoneal hemorrhage, liver failure, bile duct necrosis or biliary fistula, portal vein thrombus, hepatic infarction, hypotension, or renal failure) are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/61,69\">",
"     61,69",
"    </a>",
"    ]. In one report of 270 patients with HCC treated with PEI, the incidence of major complications was only 2.2 percent, and the mortality rate was 0 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/69\">",
"     69",
"    </a>",
"    ]. By comparison, RFA is associated with a major complication rate of 2.2 to 11 percent and a mortality rate of 0.3 to 0.8 percent. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Adverse effects'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950877150\">",
"    <span class=\"h2\">",
"     Percutaneous acetic acid injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar results have been achieved with the percutaneous injection of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    , which may have similar efficacy but fewer side effects than ethanol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/82-84\">",
"     82-84",
"    </a>",
"    ]. However, there is less experience with this agent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     LASER AND MICROWAVE THERMAL ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another alternative for local thermal ablation is laser or microwave treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Laser ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous laser ablation uses light energy that is delivered into the tumor tissue through a directly inserted laser fiber. Laser ablation can induce complete necrosis in a high proportion of HCC &lt;4 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/85-89\">",
"     85-89",
"    </a>",
"    ], and it may provide successfully palliation of portal vein occlusion due to tumor thrombus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Much of the published experience is from a single Italian institution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/85,86,88\">",
"     85,86,88",
"    </a>",
"    ]. In the largest series from this group, 432 cirrhotic patients with nonsurgical small primary HCCs (single nodule &le;4 cm, or no more than 3 nodules, &le;3 cm each) underwent ultrasound-guided laser ablation using a 5.0 watt laser coupled to one to four fibers, directed percutaneously into the liver through a 21 gauge needle, with tumors treated for 6 to 12 minutes per session [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/86\">",
"     86",
"    </a>",
"    ]. At one month postprocedure, 338 patients had a complete initial response (78 percent), as defined by lack of contrast enhancement on triple-phase CT. At a median 36 month follow-up, 67 patients had a local recurrence in the vicinity of the primary tumor (20 percent), and the median disease-free survival was 26 months. Three- and five-year cumulative survival rates were 61 and 34 percent, respectively.",
"   </p>",
"   <p>",
"    Complications of laser ablation were addressed in a report of 520 patients treated at nine Italian centers with 1004 laser ablation procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/91\">",
"     91",
"    </a>",
"    ]. There were four deaths (mortality rate 0.8 percent), and the major and minor complication rates (reported as incidence in the total number of sessions rather than patients) were 1.5 and 6.2 percent, respectively.",
"   </p>",
"   <p>",
"    Although these results seem promising, the benefits of this approach compared to other means of local tumor ablation are unclear. Furthermore, the equipment is expensive and not widely available. This approach is mainly used in Europe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Microwave ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microwave ablation (MWA), in which the implanted electrode delivers a high frequency microwave into tumor tissue, has been used for hepatic tumor ablation in China and Japan for years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/27,92-98\">",
"     27,92-98",
"    </a>",
"    ]. The reported complete response rates are between 89 and 95 percent in most series, local recurrence rates are low, and three-year survival rates are 51 to 81 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/27,93,96,99-101\">",
"     27,93,96,99-101",
"    </a>",
"    ]. The largest series reporting long-term outcomes from MWA involved 288 patients treated at a single institution over an eight year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/92\">",
"     92",
"    </a>",
"    ]. The mean maximum tumor diameter was 3.75 cm, and 63 percent had a single lesion. At a mean follow-up of 31 months, only 24 patients (8 percent) had local regrowth of a treated lesion, while 76 (26 percent) developed new tumors elsewhere. Cumulative survival rates at one, three, and five years were 93, 72, and 52 percent, respectively, and were significantly better for patients with maximum tumor size &le;4 cm as compared to larger tumors.",
"   </p>",
"   <p>",
"    A single randomized trial compared MWA to RFA in 72 patients with HCC &lt;4 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/96,102\">",
"     96,102",
"    </a>",
"    ]. Although there were no statistically significant differences in complete response rate (89 versus 96 percent for MWA and RFA), or two-year local recurrence rate (24 versus 12 percent), the trial was small, and long-term survival data were not reported. &nbsp;",
"   </p>",
"   <p>",
"    One advantage of MWA over RFA is the ability to perform multiple ablations simultaneously; there is no comparable RFA system with the capacity to drive multiple electrically dependent electrodes. Nonetheless, there is less experience with this approach than with RFA, and the technique is not widely available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1248647730\">",
"    <span class=\"h1\">",
"     CRYOABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryoablation is a form of in-situ tumor ablation in which subfreezing temperatures are delivered by penetrating the hepatic surface with a cryoprobe and cooling tissues to the point of irreversible tissue destruction. One or more probes are placed centrally within a lesion and argon gas or liquid nitrogen is circulated through the probe. The cryolesion (termed an iceball) is echogenic and can be visualized and monitored by intraoperative ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/103\">",
"     103",
"    </a>",
"    ]. Normally two freeze-thaw cycles are used, attempting to achieve a 5 to 10 mm ablation margin of hepatic parenchyma surrounding the tumor.",
"   </p>",
"   <p>",
"    Postoperatively, patients must be monitored with complete blood counts, coagulation profile, electrolytes, BUN, serum creatinine, and myoglobin every eight hours. Alkaline hydration is used as necessary until the urine is free of myoglobin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/104-106\">",
"     104-106",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21847?source=see_link&amp;anchor=H25399006#H25399006\">",
"     \"Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1248647737\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the reported complications are from series of intraoperative use of cryoablation. Reported complications include cracking of the iceball, liver surface fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/104-107\">",
"     104-107",
"    </a>",
"    ], coagulopathy and cardiac arrhythmia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/106,107\">",
"     106,107",
"    </a>",
"    ], thrombocytopenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/106,108\">",
"     106,108",
"    </a>",
"    ], biliary fistula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/108\">",
"     108",
"    </a>",
"    ], bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/105,108,109\">",
"     105,108,109",
"    </a>",
"    ], electrolyte disturbances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/109\">",
"     109",
"    </a>",
"    ], iatrogenic probe injury, cryogenic shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/104,107\">",
"     104,107",
"    </a>",
"    ], intrahepatic or subphrenic abscess [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/110,111\">",
"     110,111",
"    </a>",
"    ], pleural effusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/105,106,108\">",
"     105,106,108",
"    </a>",
"    ], myoglobinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/112\">",
"     112",
"    </a>",
"    ], and acute renal failure. In a collective review, the overall complication rate was 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/113\">",
"     113",
"    </a>",
"    ]. Procedure-related mortality is 0 to 4 percent in most series, although rates as high as 17 percent are reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/105,113,114\">",
"     105,113,114",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1248647744\">",
"    <span class=\"h2\">",
"     Results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outcome data are difficult to interpret since almost all reports combine patients treated with cryoablation alone and as an adjunct to resection in patients undergoing resection who have close or positive resection margins. The only available data are from nonrandomized trials and retrospective reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/115-118\">",
"     115-118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the largest series of 235 patients, cryotherapy was used as a sole treatment modality in 78, while the majority received cryotherapy plus hepatic artery ligation, hepatic arterial infusion chemotherapy, TACE, or resection of the frozen tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/116\">",
"     116",
"    </a>",
"    ]. The one-, three-, and five-year survival rates were similar for patients undergoing combined therapy (78, 54, and 40 percent, respectively), and for cryotherapy alone (80, 52, and 40 percent, respectively).",
"   </p>",
"   <p>",
"    Most institutions have abandoned cryotherapy for treating primary liver tumors in favor of other low-morbidity ablative procedures such as RFA, which is associated with a significantly lower local recurrence (2 versus 14 percent, respectively) and complication rates (3 versus 41 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/9\">",
"     9",
"    </a>",
"    ]. We sometimes use cryoablation for lesions that would be potentially difficult for RFA (eg, those with a higher potential for local thermal complications, such as next to the diaphragm), since the extent of the freezing can be seen directly on CT, unlike the heat from RFA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H457341221\">",
"    <span class=\"h1\">",
"     POSTTREATMENT SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even patients who have a good response to treatment are at risk for disease recurrence and second primary HCCs. There is no consensus as to the optimal approach for posttreatment surveillance in patients undergoing locoregional therapy for HCC. Guidelines from the National Comprehensive Cancer Network (NCCN) suggest the following after ablation or resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/119\">",
"     119",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging every three to six months for two years, then annually",
"     </li>",
"     <li>",
"      Assay of serum AFP, if initially elevated, every three months for two years then every six months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is also important that patients with more advanced liver disease have proper monitoring for esophageal varices and assessment and treatment of their underlying liver disease, which may have a major impact on longer term survival. (See",
"    <a class=\"local\" href=\"#H457345914\">",
"     'Importance of comprehensive multidisciplinary care'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/42/44706?source=see_link\">",
"       \"Patient information: Liver cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950875456\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatocellular carcinoma (HCC) is an aggressive tumor that frequently occurs in the setting of cirrhosis. Disease extent and the patient's hepatic reserve dictate the therapeutic options. Local ablation is commonly accepted as the best option for patients with small HCCs who are not candidates for surgical resection or liver transplantation. Several methods are available for local ablation, including radiofrequency ablation (RFA), percutaneous ethanol injection (PEI), and laser and microwave thermal ablation. Patients with disease spread outside of the liver are usually considered for systemic therapy rather than liver-directed therapies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43063?source=see_link\">",
"     \"Overview of treatment approaches for hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H2\">",
"     'Treatment algorithms'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A majority of patients with HCC have underlying liver disease, which may be related to infection with hepatitis B virus (HBV)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hepatitis C virus (HCV). Furthermore, patients who undergo any of these forms of therapy are at high risk for recurrent disease and of progression to liver failure. It is important that patients with more advanced liver disease have proper monitoring and assessment of their underlying liver disease, which may have a major impact on longer term survival. (See",
"    <a class=\"local\" href=\"#H457345914\">",
"     'Importance of comprehensive multidisciplinary care'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend RFA rather than PEI for those who do not meet resectability criteria for HCC and yet are candidates for a liver-directed procedure based upon the presence of liver-only disease (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Although there is no absolute tumor size beyond which RFA should not be considered, the best outcomes are in patients with a one or two lesions &lt;4 cm.",
"     </li>",
"     <li>",
"      RFA can be performed percutaneously, laparoscopically, or by an open (laparotomy) route. Although the open approach may be more effective, at least in the United States, most patients are treated by interventional radiologists using the percutaneous approach. Tumors at the inferior edge of the liver should not be treated percutaneously (and instead by a laparoscopic or open approach, or by an alternative means of local ablation such as PEI) if the stomach, duodenum, or transverse colon lies in close proximity to the tumor.",
"     </li>",
"     <li>",
"      PEI is uncomfortable and requires more treatment sessions than RFA; in addition, it can be difficult to visualize the limits of the lesion on ultrasound because of the bubbles formed during the alcohol injection. We typically reserve PEI for treatment of small HCCs (&le;3 cm) in patients who are not suitable candidates for surgery whose tumors are in locations that are unsuitable for percutaneous RFA, such as adjacent to the gallbladder.",
"     </li>",
"     <li>",
"      There is no consensus as to the best way to assess benefit from locoregional ablative therapies. Bidimensional perpendicular measurements of tumor dimensions before and after treatment are not useful as they disregard the extent of necrosis. Guidelines from the European Association for Study of the Liver (EASL) suggest that estimated reduction in viable tumor burden (nonenhanced areas using dynamic contrast-enhanced imaging techniques) be incorporated into definitions for response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4\">",
"       4",
"      </a>",
"      ]. In patients with elevated serum levels of alpha-fetoprotein (AFP), this marker can be useful to follow response and provide an early screening test for progression by imaging. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Assessing response to locoregional therapies'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=see_link&amp;anchor=H361320196#H361320196\">",
"       \"Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization\", section on 'Assessing response to locoregional therapies'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/1\">",
"      Llovet JM, Di Bisceglie AM, Bruix J, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/2\">",
"      Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228.",
"     </a>",
"    </li>",
"    <li>",
"     WHO Handbook for Reporting Results of Cancer Treatment, World Health Organization (Ed), WHO Offset Publication No. 48, Geneva, Switzerland 1979.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/4\">",
"      Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/5\">",
"      Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/6\">",
"      Riaz A, Miller FH, Kulik LM, et al. Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA 2010; 303:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/7\">",
"      Forner A, Ayuso C, Varela M, et al. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 2009; 115:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/8\">",
"      Llovet JM, Real MI, Monta&ntilde;a X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/9\">",
"      Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/10\">",
"      Riaz A, Ryu RK, Kulik LM, et al. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 2009; 27:5734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/11\">",
"      McGahan JP, Brock JM, Tesluk H, et al. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992; 3:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/12\">",
"      Tanabe KK, Curley SA, Dodd GD, et al. Radiofrequency ablation: the experts weigh in. Cancer 2004; 100:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/13\">",
"      Choi D, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/14\">",
"      Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/15\">",
"      Llovet JM, Vilana R, Br&uacute; C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/16\">",
"      Kim YJ, Raman SS, Yu NC, et al. Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Am J Roentgenol 2008; 190:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/17\">",
"      Sartori S, Tombesi P, Macario F, et al. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 2008; 248:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/18\">",
"      Head HW, Dodd GD 3rd, Dalrymple NC, et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 2007; 243:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/19\">",
"      Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/20\">",
"      Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/21\">",
"      Khan MR, Poon RT, Ng KK, et al. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma. Arch Surg 2007; 142:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/22\">",
"      Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 2002; 179:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/23\">",
"      Yamakado K, Nakatsuka A, Takaki H, et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008; 247:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/24\">",
"      Kagawa T, Koizumi J, Kojima S, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 2010; 116:3638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/25\">",
"      Morimoto M, Numata K, Kondou M, et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010; 116:5452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/26\">",
"      Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/27\">",
"      Yin XY, Xie XY, Lu MD, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 2009; 115:1914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/28\">",
"      Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/29\">",
"      Shirato K, Morimoto M, Tomita N, et al. Small hepatocellular carcinoma: therapeutic effectiveness of percutaneous radio frequency ablation therapy with a LeVeen needle electrode. J Ultrasound Med 2002; 21:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/30\">",
"      Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/31\">",
"      Shiina S, Teratani T, Obi S, et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62 Suppl 1:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/32\">",
"      Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001; 11:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/33\">",
"      Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/34\">",
"      Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/35\">",
"      Takahashi S, Kudo M, Chung H, et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007; 72 Suppl 1:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/36\">",
"      Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/37\">",
"      Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/38\">",
"      Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/39\">",
"      Rossi S, Ravetta V, Rosa L, et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 2011; 53:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/40\">",
"      Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012; 107:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/41\">",
"      Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/42\">",
"      Horiike N, Iuchi H, Ninomiya T, et al. Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep 2002; 9:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/43\">",
"      Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003; 38:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/44\">",
"      Harrison LE, Koneru B, Baramipour P, et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/45\">",
"      Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/46\">",
"      L&uuml; MD, Kuang M, Liang LJ, et al. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. Zhonghua Yi Xue Za Zhi 2006; 86:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/47\">",
"      Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/48\">",
"      Zhou Y, Zhao Y, Li B, et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010; 10:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/49\">",
"      Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2012; 57:3026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/50\">",
"      Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/51\">",
"      de Ba&egrave;re T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/52\">",
"      Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/53\">",
"      Kasugai H, Osaki Y, Oka H, et al. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology 2007; 72 Suppl 1:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/54\">",
"      Dodd GD 3rd, Napier D, Schoolfield JD, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 2005; 185:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/55\">",
"      Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/56\">",
"      Fujimoto T. The experimental and clinical studies of percutaneous ethanol injection therapy (PEIT) under ultrasonography for small hepatocellular carcinoma. Acta Hepato JPN 1988; 29:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/57\">",
"      Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12:S319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/58\">",
"      Brunello F, Veltri A, Carucci P, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol 2008; 43:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/59\">",
"      Yin XY, Lu MD. Percutaneous ablation for small hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2009; 3:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/60\">",
"      Hasegawa S, Yamasaki N, Hiwaki T, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999; 86:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/61\">",
"      Livraghi T, Benedini V, Lazzaroni S, et al. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998; 83:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/62\">",
"      Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/63\">",
"      Pompili M, Rapaccini GL, Covino M, et al. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001; 92:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/64\">",
"      Shiratori Y, Shiina S, Teratani T, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003; 138:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/65\">",
"      Ho CS, Kachura JR, Gallinger S, et al. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety. Cardiovasc Intervent Radiol 2007; 30:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/66\">",
"      Lencioni R, Crocetti L, Cioni D, et al. Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study. J Vasc Interv Radiol 2010; 21:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/67\">",
"      El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/68\">",
"      Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J Hepatol 2005; 43:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/69\">",
"      Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/70\">",
"      Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000; 88:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/71\">",
"      Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/72\">",
"      Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997; 7:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/73\">",
"      Okuda K. Intratumor ethanol injection. J Surg Oncol Suppl 1993; 3:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/74\">",
"      Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/75\">",
"      Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma &lt; or =4 cm. Gastroenterology 2004; 127:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/76\">",
"      Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/77\">",
"      Huo TI, Huang YH, Wu JC, et al. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. Scand J Gastroenterol 2003; 38:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/78\">",
"      Cho YK, Kim JK, Kim MY, et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/79\">",
"      Orlando A, Leandro G, Olivo M, et al. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009; 104:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/80\">",
"      Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/81\">",
"      Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001; 92:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/82\">",
"      Ohnishi K, Nomura F, Ito S, Fujiwara K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology 1996; 23:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/83\">",
"      Liang HL, Yang CF, Pan HB, et al. Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. Radiology 2000; 214:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/84\">",
"      Germani G, Pleguezuelo M, Gurusamy K, et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol 2010; 52:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/85\">",
"      Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 2001; 221:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/86\">",
"      Pacella CM, Francica G, Di Lascio FM, et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J Clin Oncol 2009; 27:2615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/87\">",
"      Giorgio A, Tarantino L, Farella N, et al. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur J Ultrasound 2000; 11:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/88\">",
"      Pacella CM, Bizzarri G, Francica G, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol 2005; 16:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/89\">",
"      Ferrari FS, Megliola A, Scorzelli A, et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiol Med 2007; 112:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/90\">",
"      Lu ZH, Shen F, Yan ZL, et al. Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation. J Cancer Res Clin Oncol 2009; 135:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/91\">",
"      Arienti V, Pretolani S, Pacella CM, et al. Complications of laser ablation for hepatocellular carcinoma: a multicenter study. Radiology 2008; 246:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/92\">",
"      Liang P, Dong B, Yu X, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/93\">",
"      Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/94\">",
"      Ohmoto K, Miyake I, Tsuduki M, et al. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999; 46:2894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/95\">",
"      Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996; 110:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/96\">",
"      Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005; 40:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/97\">",
"      Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007; 72 Suppl 1:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/98\">",
"      Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology 2009; 251:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/99\">",
"      Dong B, Liang P, Yu X, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003; 180:1547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/100\">",
"      Yamashiki N, Kato T, Bejarano PA, et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol 2003; 98:2052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/101\">",
"      Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 2010; 17:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/102\">",
"      Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/103\">",
"      Morris DL, Horton MD, Dilley AV, et al. Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion. Gut 1993; 34:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/104\">",
"      Onik GM, Atkinson D, Zemel R, Weaver ML. Cryosurgery of liver cancer. Semin Surg Oncol 1993; 9:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/105\">",
"      Onik G, Rubinsky B, Zemel R, et al. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer 1991; 67:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/106\">",
"      McKinnon JG, Temple WJ, Wiseman DA, Saliken JC. Cryosurgery for malignant tumours of the liver. Can J Surg 1996; 39:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/107\">",
"      Morris DL, Ross WB. Australian experience of cryoablation of liver tumors: metastases. Surg Oncol Clin N Am 1996; 5:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/108\">",
"      Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995; 76:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/109\">",
"      Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours--a practical guide. HPB Surg 1995; 8:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/110\">",
"      Homasson JP, Thiery JP, Angebault M, et al. The operation and efficacy of cryosurgical, nitrous oxide-driven cryoprobe. I. Cryoprobe physical characteristics: their effects on cell cryodestruction. Cryobiology 1994; 31:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/111\">",
"      Ravikumar TS, Kane R, Cady B, et al. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991; 126:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/112\">",
"      Solomon B, Soulen MC, Baum RA, et al. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999; 10:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/113\">",
"      Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998; 43:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/114\">",
"      Jansen MC, van Hillegersberg R, Chamuleau RA, et al. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005; 31:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/115\">",
"      Haddad FF, Chapman WC, Wright JK, et al. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998; 75:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/116\">",
"      Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol 1998; 14:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/117\">",
"      Wren SM, Coburn MM, Tan M, et al. Is cryosurgical ablation appropriate for treating hepatocellular cancer? Arch Surg 1997; 132:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/18/36138/abstract/118\">",
"      Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1988; 61:1889.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines available online at  www.nccn.org.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2487 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-3AAB480B33-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36138=[""].join("\n");
var outline_f35_18_36138=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H950875456\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Treatment algorithms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H457345914\">",
"      Importance of comprehensive multidisciplinary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ASSESSING RESPONSE TO LOCOREGIONAL THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      RADIOFREQUENCY ABLATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Patient selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950876927\">",
"      RFA versus PEI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950876859\">",
"      RFA versus surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950877323\">",
"      RFA as bridging or downstaging therapy in transplant candidates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H104900276\">",
"      RFA plus TACE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H950876074\">",
"      PERCUTANEOUS ETHANOL INJECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950876081\">",
"      Patient selection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H950876088\">",
"      - Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950876095\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950876102\">",
"      Results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H950877120\">",
"      - Versus RFA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H950877183\">",
"      - Versus surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H950877211\">",
"      - PEI plus other local therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950876116\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950877150\">",
"      Percutaneous acetic acid injection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      LASER AND MICROWAVE THERMAL ABLATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Laser ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Microwave ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1248647730\">",
"      CRYOABLATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1248647737\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1248647744\">",
"      Results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H457341221\">",
"      POSTTREATMENT SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H950875456\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2487\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2487|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?40/37/41567\" title=\"algorithm 1\">",
"      Treatment algorithm for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?11/36/11855\" title=\"algorithm 2\">",
"      Barcelona Rx algorithm HCC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2487|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/62/33771\" title=\"table 1\">",
"      Okuda staging system for HCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/48/42764\" title=\"table 2\">",
"      RECIST response criteria solid tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/46/28396\" title=\"table 3\">",
"      Modified RECIST for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/21/8540\" title=\"table 4\">",
"      Child Pugh classification",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=related_link\">",
"      Clinical features and diagnosis of primary hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25194?source=related_link\">",
"      Epidemiology and etiologic associations of hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/32/36362?source=related_link\">",
"      Liver transplantation for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21978?source=related_link\">",
"      Management of potentially resectable hepatocellular carcinoma: Prognosis, role of neoadjuvant and adjuvant therapy, and posttreatment surveillance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41114?source=related_link\">",
"      Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/59/17337?source=related_link\">",
"      Overview of the complications, prognosis, and management of cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43063?source=related_link\">",
"      Overview of treatment approaches for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?43/42/44706?source=related_link\">",
"      Patient information: Liver cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21847?source=related_link\">",
"      Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29526?source=related_link\">",
"      Pyogenic liver abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/6/14442?source=related_link\">",
"      Surgical management of potentially resectable hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/61/39898?source=related_link\">",
"      Systemic treatment for advanced hepatocellular carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_18_36139="Test cost and diagnostic yield";
var content_f35_18_36139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Test cost and diagnostic yield in patients with syncope",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Test",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cost, $",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnostic yield, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cost per diagnosis, $",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        External loop recorder",
"       </td>",
"       <td>",
"        201",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        529",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tilt test",
"       </td>",
"       <td>",
"        594",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        1024",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Holter",
"       </td>",
"       <td>",
"        328",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        1562",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Internal loop recorder",
"       </td>",
"       <td>",
"        4916",
"       </td>",
"       <td>",
"        88",
"       </td>",
"       <td>",
"        5586",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrophysiology study (SHD)",
"       </td>",
"       <td>",
"        3663",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        7044",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echocardiography",
"       </td>",
"       <td>",
"        1033",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        34,433",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrophysiology study (no SHD)",
"       </td>",
"       <td>",
"        3663",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        73,260",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SH: structural heart disease.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Krahn AD, Klein GJ, Yee R, Manda V. Am Heart J 1999; 137:870.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36139=[""].join("\n");
var outline_f35_18_36139=null;
var title_f35_18_36140="Muscle weakness child";
var content_f35_18_36140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of acute muscle weakness in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Anatomic region",
"       </td>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"7\">",
"        Cerebral cortex",
"       </td>",
"       <td>",
"        Intracranial hemorrhage (SAH)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Head trauma (EDH, SDH)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke (thrombotic or embolic)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brain tumor*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postictal Todd paralysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemisyndrome migraine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alternating hemiplegia of childhood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        Spinal cord",
"       </td>",
"       <td>",
"        Spinal cord trauma (eg, EDH)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spinal cord tumor*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Discitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidural abscess*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transverse myelitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular abnormality (ie, stroke)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anterior horn cell",
"       </td>",
"       <td>",
"        Poliomyelitis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        Peripheral nerve",
"       </td>",
"       <td>",
"        Guillain-Barr&eacute; syndrome*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ciguatera poisoning*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heavy metal poisoning (eg, arsenic, mercury)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paralytic shellfish poisoning*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute intermittent porphyria*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other acquired peripheral neuropathy&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Neuromuscular junction",
"       </td>",
"       <td>",
"        Botulism*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myasthenia gravis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Organophosphate poisoning*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotoxic snake envenomation*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tick paralysis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Muscle",
"       </td>",
"       <td>",
"        Rhabdomyolysis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Viral myositis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pyomyositis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Periodic paralysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trichinellosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Other",
"       </td>",
"       <td>",
"        Electrolyte disturbance (eg, hypokalemia, hypophosphatemia, hypocalcemia, hyponatremia)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug-related&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conversion disorder",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SAH: subarachnoid hemorrhage; EDH: epidural hematoma; SDH: subdural hematoma.",
"     <br>",
"      * Life-threatening condition.",
"      <br>",
"       &bull; See UpToDate review: \"Overview of acquired peripheral neuropathies in children\".",
"       <br>",
"        &Delta; See \"Polyneuropathy drugs toxins\" table.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36140=[""].join("\n");
var outline_f35_18_36140=null;
var title_f35_18_36141="US reported cases of chancroid 2009";
var content_f35_18_36141=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Chancroid - reported cases: United States, 1981-2009",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 574px; height: 288px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention.",
"     <a href=\"file://www.cdc.gov/std/stats09/figures/47.htm\">",
"      file://www.cdc.gov/std/stats09/figures/47.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36141=[""].join("\n");
var outline_f35_18_36141=null;
var title_f35_18_36142="MVG restrictive cardiomyopathy";
var content_f35_18_36142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Tissue doppler echocardiogram can distinguish restrictive cardiomyopathy and constrictive pericarditis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 445px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The schematic diagram shows the early diastolic pattern of the myocardial velocity gradient (MVG), measured by tissue Doppler echocardiography, in normals and in patients with a restrictive cardiomyopathy (RCM) and constrictive pericarditis (CP). The sign of the MVG depends on the relative fastness of subendocardial or subepicardial velocities; it is positive if subendocardial velocities move faster and negative if subepicardial velocities are faster. The MVG during both isovolumetric relaxation (IR) and rapid ventricular filling (RVF) phases are reduced in RCM compared to CP or normals.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Palka, P, Lange, A, Donnelly, JE, Nihoyannopoulos, P. Circulation 2000; 102:655.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36142=[""].join("\n");
var outline_f35_18_36142=null;
var title_f35_18_36143="Rheumatoid nodule CT";
var content_f35_18_36143=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rheumatoid nodule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 297px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEpAVQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5wkJHSoWJPU0OTnrTaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAE/GgdaOtHvQAh6mkNL3oxQAlHeij6UAKMevNAx6mmilHrQA7jjnikPPU0KD19KaaABsDoaRaDSUALSGl7UhoASlHSk7UUAL2pB1paNuBmgBeKUYB4ptKOOlAEinIpaaCc9KdQAUUZHpRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAIKdj3xQKB3NACfSkpxPNN70AJjikJpe1NNACg80UgODRmgB3amUo/GjGKAEpKDQaAFzxR2pKXoKACikpRQAoFFHelxzQAAcUvekooAcKWkBxTh15oAXFFLRQAyiiigAopaKAEopwFIeBQAYpdvvSFs4oBoAdgUhwDTc0E80AOyPSjPtTM0tAD89qMr70zNAoAeFB74+tKIGb7mG+hpnNJkg0AK6MnDKQfemnpTw5GMMR680qylTnCn6jNAEdL2qx9pBUhoYTnvtwac9zDtX/RIRxgkbv8aAKueKQGrBuIiMfZohx23f40qXaoBi3g+pXP8AOgCqx79qfGjyELGjMT2AzVz+1ZkTbEsCA/3Ylz/Kq0l9cOMGV8egOKALS6VcgEzmK3AGf3r4P5daaYLGJf3ly8r+kaYH5mqDOzHLEn8aaTzQBPK0G4+VGduf4jmmeeR0Cj6CoqSgB5cnqaQH1pO1IKAFNIeKD0ooAXtRmkooAfvJ68/WnEqf4cH2qMUtADjijNB6UA5oABTttIKdnnFAABzRRSjrQAtFLRQAylpKUc0AKBmkJxmlHfFIRmgBAeeaTNL3oxQACigdaCOaAEOM5pM80pFIQCBwc0AIKdjNAHtS4OaAG45pw6U9ULMAoJJ7Cr0ei6pL/qtNvX4z8sDHj16UAUMU01qjw7rTDK6RqJHr9mf/AAqCfRtTg/1+m3sf+/Aw/pQBnE0DnApWRlOGUg+hGKbzigAJyMGhugpMHjiigABoNA4pcHHSgBKSl/CjFACDpR3qSGGSZ1SGN5HPRUBJP4Cty08GeJbtd1voOpuvqLZ8fyoAwM9KQ11R+H3i4EA+HdTB/wCvdqo3vhHxDZDN3omoxD1a3bH8qAMPtTauNpt8oYtZ3IC9cxNx+lQPBKg+eJ1B9VIoAioNKQR1FJQAtFKKO1AAKXikApaAClHWkooAWlB4NJQKAHg04deaZS54oAeT6mikooAUg0o4PSnfwj1pOwoACKTFLmkzQAY5pdtIDXQeCvC2p+L9ch0zR4TJM/LMfuxr3Zj6UAY1paTXc6Q20UkszkBURSxY+gAr3bwT+zpqWp2cd34jvxpqOu5bdE3yj/ezgCvafhd8L9K8B2ausaX2sNxJeMuCB6KD0FdzqOq2OmRB9QuoLcHgb3Az9KAPnqT9nDTbUu1zrspTOR+7C8fnXI6/8NfB2jlxPr8gZD8yhlJ/LNen+P8AxtBrV2+n6XBJOinBdyFT61wc3hK0vAbm9iR8DiMHDN9D0oA499L+Hdoqo19qFy+fvIBgj3FekeBLT4VX6w28Wn28txwoa8+8x9wTWXB4U8LywTf6JGJSMBZ3A2n0BBqrb/DS1huUuIJdi5J253D6A8UAfQejeDvDtvGh03StMRQf4IVP611MVpChG1FGBjgV5F4V1G80FY1eJZIMYPlA7jx3Bq3f/G7w5pN69rqQvIZ0+8phP50AerNHGBkjoOtZfmrPLtWMMoOCxxXjvjT49aZHYsPD5S4kYcFm24z6gisHwT8ZNRuJIYNVgt5UbOZIplVh9QaAPeL/AMG+HdURhqOjWFwWGCXhUn86828Y/s+eF9TtHOho+l3ecqyEun0Kk16H4d8V6dqVoji5iRznKlxkVY1DxdoFipF1rFjGT0BmXNAHyZqnwE8V21/Jb2SQ3aocBwduR61gax8IfGulRtJPoc8ka5JaH5/5V9I+IfjDoXh6F721nh1NHcxlIZfnBHqPSuPuf2moZUMVj4dl89vlQtODz24AoA+ZruzntJ2hu4JYJV6pIhUj8DUaRNIwVFLMegUZJr1b4p6prviTxPo194q0tbaCRURIoBh3jLAn3JOa9d0vx18M9HuUht/DM9k0RCiT+z+SRx16mgDxnwH8FfEvilllmi/sqzIDCa6Q5YH0WvefCf7PfhPSoUbWEk1a57mRiifgoNdNB8WPBk0bGHV4FEeN27K4rbtfHnhW6C+Rr2nOWAIUTDPPtQAaV4O8O6AA2kaNY2jgY3xxAN+fWtaK3hkPzZLA+vSuR8TfECy0+UQ2dleX7ld2+2jyoGM9TXLeH/jJZm4kTXLT+zkD4DTzJu/75BJoA9ektkZgTniqOo2uYSYyN/bd0riNY+N3gmwt98eqrcv08uFCx/livAfiN8c9X8QT+Vojy6bZr02Eb2+poA+hfEXiPSPD9u6ardWKyiMu6llBPtt6mvn7xN8VoLlNUjtbZJnlb/R5GiXEQ9q8gv8AUrm/uXuLyeSeZuWeRsk/jVUyUAddP4v+0RhbrT7WUhQMtGuSfU8ViC7snL+fYRksc5Q7cVlGSk380Adr4E0/QL7xDaJqNxHBbF8Otz0I+tfXzfDDwReadFC/h7TniCALIiYJGOu4c18GeZ7V6R8Nvi9r/g68t45Lma+0hPlazlfIA/2SehoA9U8bfs4Q3Eslz4P1BIUxn7Jc5bn2b/Gvn3xJ4a1Tw3ftZ63ZTWk46B1OG9we4r688KfFfwh4gukubfWRply42vZ3p2Bj7Hp+tdh4t8OaP400KS01KGC4jZT5Mww3lsRwykUAfn1jFG2t7xh4eu/DOv3mm3isGhchXIwJF7MKws80AJijFLmkyNvfdn9KAFxS9qQHmlJoAdxRSA/5xRQA/PtSE0vekJoAQnilBGAep7iko/CgCxY28t5dw29sheaVgiKO5Jr7S+D/AIa0rwF4WCXcluNSky9zPxn/AHc+grxP4NeDoY9Oh1+9XN5PL5VpG3GB/fHv1r0rx9cNZ26Wce/BAM79T+FAG34x+KQt5ja6K0CoeDcuckcdlrxTXPEiyXrXmrat57MeFlyfxAzWd4t8QWGiWyRwBby+dTjzBjaD3I9a8ov72e/uXnupC8jHJzQB6Nc/EW2s5HbSrCKSR2+Z5hkEewqjqfxR1e88oxQwWxTr5Y4YehBrz+igDq/+E71gTSyI8Kh+dojGFPqKv2vxP8QwxhDcJIncOgOa4WigD17RvjFdR3EP9pWcbwICCsTFcn1wc1q6h4q8IeK4/L1lRFMzlUlKncq9ssK8MpVcr0NAHWeNPC0+kXMk1i5vNLGNtynI59cdK5VJpEOUciug0nxLc2lnPaSSF7WVCrRkA1i3SwkCSA4B6qe1AFq21/VbWPy7bULmJOeEkI61Umvbqdy808jt6s2ar0qKXYKoJJ6AUASee5UqWO09a9f+AVx4Dt9QNx4w+TUYJFktnlJMWR7Dv9a8mn066gQPLEyKe5quu5WGMjmgD7o8Q+JfhbqUlvNrd/otxLbgPE7HLJg5GMc1U1D4pfDKG0kkN5YzsuSqJbksx/Kvi/7JdSEFIJGz6KT1rr/DHw91LWoFndhbwk4JYEkY9cUAc9qd+19rN7cWypGlxLJII1XAUEk4q94c/tKC8iOmSPHcP9xki3HPTAr2Hw38JreRQLtGO47lOwAlfz6V674T8BaZphs5fIjSSFfl2oPrkmgD51ufBPj6/wBPlvrp76Vt/lqjSn5h6jnFcJrWgazprp/aVjPG7lgCTu3Edfyr73kSFUKhUZeuSOM5rkvEPh2xvMJNaJIxBRSoAILdSM0AfDTZ7imN9K+u774N+GrwGFLJ1w2BIG+Y8ck+1eZ/En4Iz6PBFceGDc3wdjujYDKjtigDw48Y4qLI9K7zS/ht4mvrgRz6XPBEFJMsi4VcetYXivw1ceHtQ+zSsJgV3B0HFAGBRSsMUlABRRRQAqsR0NdX4Y+IXibw2oj0vV7qK3zzCX3IfwPT8K5OigD2XxLrcHj/AMKxzXdtGNYiyY5o256cqw9DivH3BR2VlwwOCK3vA+uf2Rq8S3BzYTuqXA9FzyR719Xav8E/BfiXRI59NiaznmiWSK7hbO7IyCR0NAHxjmkzxXTePvCN/wCDPEdzpWoocxnMcu3Cyp2YVzRxzQAZpQaQ/SlGBQA8H2opv4UUASk80mcmnHGab3oAAM16/wDC34L6t4oVdR1ZJNP0tcMpkTDTDGflB7e9T/s3eArbxX4jmv8AVIxJp+ngMY25Ekh+6D7cE19W+L9Th0Hwxe3jqRHFHtVU45PAAoA8ji1mKDVLOGK2SKMHyrUNjhFGC2B9K5L4r6mbOznvzdMGyBGm7/WGuC1Txo9n4gm1FY/OjjRkt0kJyM8flXnGs6td6vdvcXkrOzHO3PA+goAr393NfXUlxcuXlc5JNQUUUAFFFFABRRRQAUUUUAFAopV60AOhieZ1SNSzHsK6+HQZrbSnYxI8q4feDyBTLK1uNLtrO5t0Us6GRjwwPt+VXbbUJNRjSJZfs5HPynAPOelAGHc+e1uyys+3rtzkZz6/jXRfDLSre51uGbUYEltRksj9CMHn9KZeWv2Zh56hoplIWWNslyOvHavRtFW1fTNPWAIzSQAxF12LnJBzjvjtQBLHdaVrWsE20BgtLWVUJwFJXbwfoK9l0UW32VIYYliZU2rgfeGBzWT4J0GG30cvLHGXVyGAQYbHp3x9a7a2lgjtiNmxAejcUAMhCI5QRAoFwGx+gq7FII4gFG5AMY759KqBlWQBW3YPGDzjjmnwbihflWZiTnnAB4oAtSFQf4U5zt6VS2DzQygkA+uf59Kk+V3B3hgoycUgcLg7g+49+gA96AI3dgGBHfAOeR/jUmARsYMBt3OQDiobiSONDM0hjYgKoIyDnpU6JEGWNGbOQTg9cdaACWGK4iaNl2xmPB+h9q5k+EtJ1FzFcRI8SZXYUBByOe1dOJ1QStk43fMOuay7K6dZ5WYptL4C59aAPmD48/DOLwddwX+k+Y+mXbHKleIG7Ln0NePng190fEnQ18XeE5tMICeYQQTwQwOQc18Ta3p82malc2V0u2e3kaNx7g4oAoUUUUAFFFFABX11+y/49j1nw8PDd86i905B5BZuZYsn/wBB4FfItaPh3V7vQdatNS0+Ro7m2kEikHGcHofY0Afavxy8DweLvDEsyIP7QtI2aFwuSe+P0r4imQxyMjjDKSCD2NfaPhz4w+HvE2n2lmJZI9Uu4Pmh2HCvjkZr5R+JGm/2V4z1W2IwvnM6/QnNAHMHFFBxS8UAAFFSxwvIuUXIziigBDQvLAUE0sRHmL9aAPuL4AaBHoXw/tNq4mugJ5D6kgYqb4xa7bafpUFhKQ0lwd/l/wB4D37ViWfxH0nwd4d0a0vN8jy2oZQg6bVHU14n8RfEl1r3iW91C8LxqkQ8lCMoB1H86APOvGHnXWovdNF5cUhKqAMYwSMcVgmxuRF5vlMY/wC8BXufgK+8O2/hUJ4quII4JiWUEZbJ7jjPFdlp+ofDy904WulXFlJKp5E3yFvwbGaAPlEjFFdP8R7WG08W6hHbLGsJcOojxtAIzxiuYoAKKKKACiiigAooooAKUUlA60Aey6NpKXHhPTJIwgDjftJzv7EA9q5rxT4dutGmF0QPs4YKyqD8np25GK7P4fs918PrQ2zbZIZXQ4IBBBzn8j0rpfEGlpdWbR6lHJPmMZkZh124BI7UAeRRXDXCx+S/ybsfIuGU47V2mkahH/ZsRfzI2RztWMYGRxyPXj8a5q10poJgRLtTcQEVdzEA4IyOn1rsNE0aSfJ3KsTk7W5y+Oxxw1AHr/h7UpksJZLkpIoYBTG2cAj+IdjXSCaGaMtGCXOMqTzXn/g4rZW88N4VXcN+VPJzXV2Mdt87x+YSkm8tvz1GOKANg3W1wzlUd2EaALwOM5/nVnJVBKRhQcMc5APtVKK5QskcaHg/OzDPbirCzJKisgdFHJYHK5z6UASyLOzW8cSDP33Vj0H1FK8aSbRFuYM+GCnuO1L5j7JJSCin5FIIJPuafFEQQSu8bcKQMUARvAzRr5h+VCCFHQGpV3BU8xvmOTxwce1EoIjcI+EQ5JK5pLdpJ4RlwcMck9x7CgCPb9oCmMsI92GVuCTVKK1X7XtJRgpxtPUfjWoka+awXAIGEyDVedTG+CqknptGTmgBmoxxyWbxsqgN8oDHIx618uftCeC5ND1aPVLK3b+zZ1VZJsjb5pJ4/Kvq5iscEkhHz4+tfOf7UmtTXFroenA4iG6aRV4Ut0H6ZoA+eqKKKACiiigAooooA6f4eTiDxlpDswQecAWboAeK7H9oK0VPE1neR7T9ot8MVz95Tg1w+k6TepNpF59nmW3uJgI5Qp2khsHB6V6j8dIoJ9E065iw0iSEFgp4BHc9KAPGLR1SXDxJIG4w2ePyNRHqans4TNOAHjTB6u2KibhmHvQAmSO5op2CO1FAAaRD84pSKfBEZJkQA5ZgKAPSfE0lxq9/4csA6BzaqC688HrkfhVj4kxgW10qv57wKisQhXaOBz+ldQnw58QyaxpWrafaMYLeDczM3oMgD860YPDdqdJ8TtrMqDUNQjwo/uk8gDn1oA+cmkZgASSBwPakw4QPg7fXHFXdW02XStUnsrvb5sTbW2NkfgRXoeqa94YTwPaaVYaeJNQmUBsnAVumSaBpNuyPLJXZj8xJNR1NdQyQStHKjRuP4WGDUNJO+qHKLi3GSs0FFFFMkKKKKACiiigAoHWiigDvvhdraW0tzo9xny78p5Lf885geD+teqeKdSFlCtnKUE8JxK2/ggjpn6dK+cradreaOWM4eNgyn0I5FdV4j8W3HiRklvIYUuGAEjRjaHPrjtQB189zHeXEV5ahRHvB2Y2EdOvqOK7fw/qMEcTRyB/MJUqi9+Ofoa8Q0+7vIrxYkOUlUIQehH1r0nwat4+4GOZ2kbIRsFVUAhjQB6pIpWxubqGbzIZLfLxYDtGx4x39a3tPD/ZovmV0CrkdCuRyPftXHad5h0iRwYprhMgbeCwwflwOO1dVot9bNbDGFlMaF4933Mdsd6AOigaOIgqpYKhLovzEelEDxRkOGIymUi6HH+PFZy4DqVkCvJ+8GDkhfQ/nSxQrI3nM+0lyqlR0A7mgDX+0oTiQl0HzFCOfyFW0mjXI3BAgxnsDjt71lBiwWc/vMsFVwAARnip4LdSVBD5T5iOOue1AFgiOQJEpIjYEOwHU9hVyKRdvyhMoNox3qiJUXf5jhQpwpB4LGksI4yCARGfvcd/egDQ3xrIXLEEEjI6LVaRgswmmGSq/w85/CpJE33CRuhfA3bx2+tV72JTKoUB1UcEjPNAE8OWDb1GT0HY18x/tQZbVdLZwqP5bgIDk4zwa+pLcRuMd8ZyRXxh8eNSttQ8c3X2O5e4SEmJmPQEMchfagDzeiiigAooooAKKKKAPt3wZ4Th1D4D6Tpe0Cd7ETxOOqyn5wR+OK8Z8VHUvEHw2u5Psyf6DJtmbO3lMZIBP8q+iPgzci8+F3hqUEH/Q0Q/Vfl/pXknjizTRtC8RJHK4WdrkrBJcrGr5yCdhGWx9e1AHzHH/AK1frSPjc31qa0m8icMI437YdcjrUUg/ePx3NABnPU0UYPaigBTWt4UtDfeItPthjMkyrycDrWSa7f4O2AvvHWm7wDHHKrtkZ4BoA+7NJso7LS7W0RRsiiVPrxivhX4l6rqFl4t1a18x4liupFVATgDdgfpX3sPuivhP9oa2Fp8TtWUE/vJPM596APNXdncszEsTkk0hJPU0lFAHoFg1trWjxPeRpIQNjZ6hh6Hrz/WuEvBELqUW4cQhiF39ce9NWWRY/LV2CZ3bQeM+tXJZI76FpJWWO8QZJPAmH/xX8/r146NB4eTd7xfTsfS5lmsc3o04OKVSC1fWdl3/ABs9+mtk6FFFFdh80FFFFABRRRQAUUUUAFKrFTxSUUAdH4QuFOt24uGPlAEHkdPxr1vT8Q6YrROXhdBwDhlG4nJ5+orwONyjBlOCK9E0Txeq2sNu8rxIsZEgGP3rdvoKAPSbjUdVj0fULm3ilWB4SiuuCA6ngmrPhVrq/Rpoi0EttwfNTO9iOW4NXtL1ix1jwlqr2SxxxvDht2eDjB21b8HWs72IuIY/nZFIjYAM47Ej1OKAO40B4ri3SK6hZLvDAS7ccds/hV9kSXdHCmFQ4Tng/T1rnlvSlyWnjZJH+SMq2W47k9vpXTaZNbi2T+8CWYggkmgBIIzGsatJuTeWkAHHT/Grh/dWfDDe7AL/AHvp7UhDJIWJUKF+ZcYJ560skKt5ciKyOz5JOcgdqAFEaKjI4YsSS2erH29qp2wk+1SxsThQFyvJbuc1thTsdXIQBc7sfMR9KqwIIg0ojHzg9Dkn3NACRyiNuI2ZSNoxzz61FqDwW8ceVkYrnO3kk1OEJJEeFJx84964P4oa3H4Z0sXss+BHuWNSRmR/YUAZPxa8fnwh4fWKxulfVLsEIoYExr3Y/wAq+SLy4kuriSaZi8jsWZj1JPermv6tc6xqU13dytJLIxYlj79KzaACiiigAooooAKKKKAPs/8AZV1I3nwvW3ZiTZ3UkWCegOGH8zWL8abFL7QnnezhuXAnMcssxQRcZ6dz6V4p8J/idfeBLHU7OzgWcXxUrubHlvjG78jXZfFfULiTwbYTsWDxt12nncvOT070AeIWdu1zcBFeND1zIwUdaZOpSeRSRwxHH1qEMQwxUspJlkz13H+dACdaKaeKKAJGr2X9nTTy+rS35wQjiLG3PUZ4PavGjX0H+zKvnafqkYVdyzo249vloA+qomDwow6FQa+Gv2kpRN8Ub9lOV2rivftT+ImqaH47j8OvCk1rcQb4mQEurZOR7187fH51f4h3JAIPlJuyMc4oA84ooooAKKKKACiiigAooooAKKKKACiiigAooooAKcjFTxTaKAOp0nUr+x0e6WIssEi5JzjrxXvfwt1iWTSoPOYee0AIfqQo7Z9q+Y1upfJMe9tmMYz2r6J8FXc+ieFtNTV7FoEEQlFyDnch6DH40AehXt3Z7BKRuBLszpxkjj+tRxaokU0YtJYhDIqqF9yMkVj3v2XVdHmfSGR0CM0m5uxP3Rj868k1rxDqmk3T+eoljRsQyDjB/DoQOKAPqHR9XsZpvs80yvdquXDfeAro4YoyC+5WB5PpXxPY/E7VrK/+2Jsd88hxkEdh9K1NS+NniW5DJayi1iK4Coe/r9aAPrbV9St7OFpi67Sv3iefbFcZb+JS99NHhTZxDAkBwWYdh618r3/xH8QahMhv9QllVWDbM4HH07e1aEPxGvtoiBEaZ+Z04Y+pHoaAPqzUfFdhpejy6hNPGUX5iQeAPQDua+Sfit47vPGevTzySEWMbEW0PQKvr9TV3xV8Rjd6KNJ0u38uFgDLPK2+Rz3x6CvN3cucmgBtFFFABRRRQAUUUUAFFFFAGx4QtFvvEun20il43lG5R3Fe7fEWBYvhzNbhCMFQF242/WvK/gtbJP49sWk6JuI5wc4xX07q2nRahbPbFB5OPmLx/eI9QaAPjG3l8mXcEjfth1DD9aWdibiQ4AyxPA96277Ro4Nc1OzuLuG1+zOwDShsNhsYGAaxbkg3MpVgyljggdeaAGdaKWigBcV7h+zNceXqd+nPOwjOcd68RBAwcc17L+zferDq+oQ/KJHQOCTzxn/GgD0b4j6Zdy+OvDeq2mTtmNuwUY4bn+hrwv48lz8Rr/zM5UKvPsK+xH8Pwa7pGVkaGdZBJHKMEqQc/r0r5I+Nen3M2v3upycjz2icf3SDjFAHl9FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRU9naXF5MsVrDJNIxwFRck0AQopZgFGSeBX3Q+m2qeHtJs7uMMI7OLepXLDCDgfiK+N9C024s9cs5b/TLuSCGdTJEsZy2D93pX0J4B8Qa14xg8QRXk8unNE4FuzJ+8ijJzjB/AUARf8ACMLn7Tazywx7pN0LNtUtuG3A78GvOviv4YtdDhjniu2e6uWDvCzcj1OKrfETVfEnh7UE0u41KWa3XdJDLyCynjJHbGK5PRbjUfEOu2tnLPJNJM6oGdicc9eaANS08Bard2sVwkf7kpvJyOBjIP48CtHw94A06fUhZ+Jdc/sMyKPJllh3I7ZwVzkYx617n4e0M6Loiojb9gw3ndXJOSfyqv4l8Nadfot3fxGd4VJLHqABwFHpQB4j8QvhLrPhWA6haSRavohG5b21IIC+rAE4HvXnGD719U6W0uoizcRCOFYgiJ0UqcfIy9xgd6d4i+FPhDVQix250q/kbzA0EmInHcc8AUAfKdFdh8VbLSNM8XXFjoTI9vAiRu6HKmQD5iDXH0AFFFFABRRRQAUUUUAFAorovh3oZ8R+ONF0notzcqrn0Uct+gNAH0f8KPhta6F4K0XX7hnTUrkCaUMOiv8AdX8sfnXoM1rJEgZCANpyXJI57+1a/jW4i07S9NsYiFZ5VSNQP4UGT09hWBq135OmXMyqHZLdmGeWBxmgD5H8W3EV3rviObapZ5coVOQPn5Oa5TFdXNBu8K6tqLhjJPfLEDjjAyx5/EVyuKAEop1FAC10nw/1ZtH8TWdxvdY2bY+zrg1zZrpPDGmf2nperGMgXFtGLiMd2weQPwoA+6fA92l1pOY2BCkc/hXCfGHwTaX2mahJBEqLefNJgf8ALQc7unsKpfCHxxpqeHrGS7nEazBIpCxwFkAwf1xXret2KalpksBJ+YZUqcHNAH5t3sDW11LC4w8bFSPcGoa9E+MXhubTdenvo4m+zSthmA4D85rzugAooooAKKKKACiiigAooooAKKKKACpLaCW5mSGBGklc7VVRkk0+ytJ725S3to2klc4CqM19KfCvwDYaW1jNGpk1hwPNkYbkTv8ALkcHpQBl/B74DNqajUvGULpbMAYrVX2lvdiO3tX0Z4Y8E+H/AA1EU0jTLe3yckhMk/j1resYBb2sUQH3VAqzigCv9mgxjyY8f7oqvNpVlKJSbeNXkwGYKATjpmtAAUAUAfK/x4+EeuNqLazopk1Cz2YaEtmSIf7I7iuK/Z+04f8ACb3UlygSe2t32pIpyrZxnHtzX22wBGCMiuE8QeGbW21K41K2txE0y4lkiQAkZ5FAGdN5wtnggCsWTIYkDBz/AIVhzRSfZf3k4EjMQXccIM4G1e/NaVrd2vlFFO+ZtzJkE4Gcc/jVOSCeWVC7K9woyexUY7fnQBhmwlu1MdoX82J8nb8gZu5H+FHjzQbrUvAs8Ny7pdITJDGh5A5BHFdHDHDaQ8zMigZ+Vsnr3P1q3pOtW8Fvd6lq6hrW3jcqSPm+UZPHfOKAPhy7jkhuZIpgVkRirA9QRUVdp8XPE9h4u8Y3Oq6ZYJZQuAu0DBkI/jYepri6ACiiigAooooAKKKKACvbv2SdJW/+I9xeyJuFhaM6n0ZiFH6E14jnFfXP7KuhRaB4C1DxJfFYxekvvb+GKPPP55oA2/F2txXvxrsNLaRjHp1izlB08x+5/wCA4q546u7aw8NarqBDJJ9kkRCBx0r5ym8dg/FnU/Ezbmglnfbjr5fRcfgBRrvxH1fxY9ro8YEVvJJswoyz5PegDJ8TobHwVo1rvUNcu906qcnJwATXFk16N8ZdKsdFm0azs1YOtqC5ZyTnPcdq83yKAFzRSZooAfXUfDW6htvGFgLtiLaVzFJzjIYEf1rlu9PgdopkdDhlOQfegD0TX4Z/Cz6j4dukcRvOLm2b/YOR/h+VfUvwQ8Zp4v8ABsJlkB1GxC29yuMHIHDfiK+XPiXqMniKw0TVbfMphtAlwyjOx89zV74R+LbnwN4qsNQuYnTStQTyrjnhhn731B5oA9s+LfhizuHu7aYMsV3mTknBJ7j3Br5F17SLjR797edTgcq3ZhX334/0+LWfCkksQ80xqJoyp6jHX8q+WfHFjHqUZS6KidvuuFzjHpigDxiirWo2UllcGOUdOhHQ1VoAKKKKACiiigAooooADQASQAMmiuz+G/hhtZ1WG5uhss4nDfMpIkIOSooA7f4c6E2gaO1zewRpqF6uQJWwViH90joxr1n4cX8+pa/CX2wxxMpVOjMmOrdienSqN9Zi60sxQxMxA8xGdchfb1FZGmu2jXKXNzcmS2tSZFEQyWYDGC3YfWgD6bXmndKw/B2u2niHQrW+spFdXQbgDkq2OQa3KAGg804d6QDnpSgUAI1ZHiyZoPD93JGYwwXjzPu/jWwRXn3x8nu7b4Ua5JYoWk2AMR/ChYBj+VAGU0ljFNE9tcRXCzDAaNsoowfSq0AV7lp5Iy9zGNoCt0J6fpXyV4b8T6joF8lxaSbgOsb5Kn8K9LsPjRHbpHJc6dJLPklyHAwPQHFAHtWpLcW8RmvG2sflEQXP4muC+KvjHS9I8M39rEQ2p6hCYwo5KbupPpxmvOfFHxq1rUxHHYKtrHH90kBmx7mvMNS1C61K6e4vZWllc5JNAFU8miiigAooooAKKKKACiikNAF3RdNuNZ1my02zXfcXUqwoPcnFfWfxp1GH4f8AwY0/wxaMoubqBbMAcnYBmRvxPH415X+y34aW88XXHiLUFCado8Rl8x+F8wg456cDJrl/jR4zl8Z+Nr27VybCFzDar2CDjP44zQBwbtk1618B/Bc2qawus3aKLK2PybuCzY6ivPvBegzeJPEVrp6ZWJ3BlkxwidzX1Lqut6f4P8HXEVmhCWsISFkXjOMDk9aAPnT4vanHqXjS9eEgpGxjyO+DiuJqe9me5uZZpDl3YsT7k1EFOKAENFKV5ooAeetHeg0ZoA9i/Z9uLe5v77Sb5IJIpo9wSXBz2IAP4flWfqfh+5ttZ1DwpfSrGi75tPLDC5znAPXkZGK4Pwtqz6LrtpfoxXynBJAB4717t4stJvGvg+HULaFI9XtJPNgmA2+ap9D70AdV+zp48OqaXJ4R1p3Oo2iuIWkP34xxs+o/lXN/EbQBZ3dxJHGzwLLyiMy7Prg814lZa7d2ni+HUyBDdRzBpABtBI4YED15zXusviay8U2cHimzeCPOLbVbF3OY26LMB3XpQB5Rquhfa2kbzXCMu5ROC5/A1yN14YvopNiJuYgEKK9Z1eC6sZIz5c0cEjERPAwMRznJB4rJ/fC5/wBMt5Z5HI5kT078YoA8murO4tZGSeF0YcHK02O1nk+5DI30UmvVNTszJcKn2Z0jibIIGMfUVp2NwlujNFMj/JyNoUD1Bz3oA8UdGRsOrKfQjFNr13xna2979ke7V4isI2Myhx6nmuZXR9PfLkRBDwhbcpY/QcUAcRT4YZJn2xIzt6KM12L+GECFsqq4J/eEDPpjHWtfSLRoTCLSH7PGTkS44YDqeetAHO+HvClxe3tuLgiOBjuYkHp6fWvevD9oNPshFY2iRQrkYjIwV+p7n1ri7q7sjeQKllc28jKvmXSH7wJ+uQDXUaZPpE1got5QttETgS5+Qn1B5zQBrPqPmLJ9qae1EbYV+SJG7An0rE8ZwFvC+oPDdLbWsXluxiG4kZwx46ZrUvfOfTUEV4ktuMuSkZLBu2M9R7VxnxKvrzTvCkmnPA8Ru5FQSOvzS45P07UAe/8AwX8MWWjeH7a/07Uzfx3kIZnAAUnr+Yr0kV5/8GbF9M+H+j2mEUR2qs5HPztyf512ekreJpy/b5EmuQWO5V2hhk7ePXGKALuaAa8Hf4heLNY1Caz8iPRWS6aDytpaUqOrZIxir8mseJNPlea21trhSdoSZV2Z6dTQB7UTUF/Z2+oWU9pewpNbToY5I3GQykYINYHw+v8AWtS8ORz+JLaK3vt5XEf3XUdG9s1Z0X+0hPqcGos//Hyz20hxhoiBgDHpyKAPiH4zeHIPCvxF1XTLKHybRWWSBASQEZQeM++a4GVsnFfVf7VGl6ZFp7apLo00uozqkS6gudsW08A89xmvlOT7xoAbRRRQAUUUUAFFFFABRRRQAVa0nT7nVtUtbCyjaS4uJFjRVGTknFVQCSAOSeK+ivhRodp8K/DNx438ZRql/cp5em2jD95nGc+xPH0FAGn8YL+z+G3wu07wNosqC/uk/wBMeM4Yr1Ynv8xP5V804eSRY41LOxwFAyTWn4o1y88S+ILzVL52kurqQuR1xnoB7DpXrHwp8EQaDbt4q8XyRWtvHGHgilX5ueQfqR/OgDoPhL8PLnSNLS91Ftk92ATGAeF7AmuZ+NviSCOKPQdNmJVc/aAr5AIP3frWN49+KuqatqkyaLcy2mmr8kaocEj1NeaTzPPK0krs8jHLMxySaAGE80ozikoFAD6KaevWigCQ0lBNA6UAHtXpPwz8fXOlPHpl5KrWjN+7eU5EZ9PpXmp6UBiDkdRQB65458E3Nzcy69p8iRpIpeWNEJIf/ZC9QeK5L4f+I/8AhGtcmu5YUurVomjmgZMrIp4I9uM810/wt8cCHVILbVrl1VyFLschugC4962fFfw0sbu01DU9Ae6SZPmW1ijDRkYz1J/xoA63UbzRk8KaU1q11LpN6cWzupxCQWyrEdxnH0Fc9LE4m8mVtxyMGVTtYZ6givOfD/jK/wBBtX0m/iaexdlWW1nH3AN3K+h+Y11X21LWzt7uVVudJlG2OaFW3R46BiD1FAGtJC8MiGZmZ2/1c0cpYbRzg5Hb3pEtWe5mfz1vOhaNUXav1PU1HbxxyQG9jvhKjJlY0dk2D2J4z6irCzJbqv2OCZ5JcMGWMsufdv60AU9Xtnef9zsu5Y4wT+72rGOvTvWENNt3eZvm+0v8ybUbg/T0rbv4mvb0yztJHOrbR5Y3q317VcsLYR3EMizxXTPgSEgIsZ7DjnPtQBk2Ph/YDNJMZTIQAIwxK+q7a1XsRJN5UKGa5cYQE8xjvhCBk108VsbffMJE+0HCoQCMZp9wkTXKwTC3z95pZ5MPI390DqB70AcumkSx6g7XWWXaFMQG0oeO46n2Ga0Y/Cy3NyGk8mCGPrER87/j1zWhtdrlU+xvNFjgEBgnbAJ5zXWWWlRypCr2j+WpAUAfxnqc5yfTFAHn+q6Fcw2/2iGS4SNCJA7AgIqjrgHAHel8H+DNd8V3keq6t5raXbNmwivCczMeS5U9j159a9z0vwfFKHfVIh5Bxtg67sevt7V0V/dWei6ZcX2ovDbWFqm7JwoUDtQBjXGrQeGYPDukbI/t2oTJbpCpx8oGXb6AV2IFfE2r/FG+vvipF4q2tNbWMpa0tSTtEYGMe2RyTXqek/tM6dNdRx6loc9tCxAaWOYPtHrjAoA9p8TeG7TWbZj5aR3oyYpwvKt74614z8PJbvWPiNcWUmnXc2m6czpcMwBhMqnAJJ/MV7h4e13TfEOmx3+jXcV3av8AxxtnB9D6H2q/DDHEXMMaIXbc21QNx9TQBJgAYHArnPiDf3+keG5NU0uITS2Uizyx93hB/eAe+3P5VzfxH+L3h3wU32aWX7fqX/PrbsCV/wB49B9K8zvf2i5ZIGh1Hwq0VlcKyMXlJ3KRjuozQB7fcro3jfwsjFItQ0i+jyO4x/QivkH4v/CHU/Bk731kjXehO3yTqMmL/Zcf1rsfgT8WYtA1CTRNX/ceG5ZGa3kYE/ZmY8KT/dNfUL21jqtiySLDd2NwmCpw8bqaAPzWKkdRSV9Y/Eb9nKyvPOvfBs/2Wckt9il5jPsp6j8a+dfFHgTxJ4YJ/tvR7u1QHHmFMxn6MOKAOYopSp9KTFABRRg0YoAKVVLMFUEsTgAdzViwsLm/nSGzgkmlc4VUGSTX0H8Kvg/a2kKav4rjJZBvEDj5UHXJoAwPhR8KjGyeJfHCiy0m0PmiCYENIV5GfbisD43+M5vGXiaNrW436dEoS2tkOQnYnHqa7T4s+JL7xrqtv4W8IHzbCHBmeHhOePmPoKpNovhf4a2wm1KUalrDKCOVO04z8g7D3NAGX4E8J6d4Yjj8QeMLiCNlXfBaMCWVuoJ7E+1c18RfHt54qu3ijZotNRvkhB4OBjJrC8VeJb3xFqDy3DuIA2Y4dxKxj0FYtABRRRQAUZxRTSeaAHk8nGKKYetFAEpBzSr0o459aO9ACYyOaj6GpT0qI+9ADskEEcV6D4D+Jd54Y06WylhN3ESXj3SEbCRj3yK89NOUcUAem6rqem+NGi+0Wqwz5/11vgSAn++CORXPl9Z8E6lJEw821YlSrgmKUfT1rlYpWikDIxVgcgg4xXd+H/HYFsun6/bpd2RBDORl+e59aAN7wqLq8j/tHSbm3gdwzGxdtw74wM8itFfFFql4E160msLhX5ZQfJJH+zXEat4ethZS6r4Z1Hz7eL5mhJIkjBrq/hTruoarN9hvYbWextwXlaaPcx46fXigDpIbvSL/AIttas5EZ9wEsm1kz257Vv2FjKVWK0jikjPSUYOPoRXX+GbHwtqKlNS0S0iJYYLQLh/xr0bSNL0bTIFj062tII+iiNQKAPKbTw7fz3C77B7nb8q+am1Bnqcd/rW1p/gK93BroRNjJAWNUIJ7Z9q9TBAHammWNQWLLigDldM8GWtvMlzMxNwBjK8V01tZQW6jyokB9cc017+3QHLjg1RuNWfym8mIbs4B3DmgDTubiG1haW4kWONRksxwK+RPi544uviB46i0KxuvL0VJxDGA2FkPGXbse+K+h9cs7LUnW31O6IllU4UtjgdcV5re/BXQVmM8F1OFa4ExIIJQA52qcd/egDQ0Pw5otlpiabJb21ydvWSMEkZqj450bRL+xktF0eznufLXEUEYhmjXPJU45rqNY8N2+vJDbxXlxB5Kja0Y2sw+tRxeH4o4o0mlWae2x5FxI37+Mf3c9waAPGvBV7f/AAr8Y2Vzb3n2rw5eyiC5IJwvODkdmXPWvfPjp4wn8KfD6a70xsXl26wQOM/Lu5LflXJW/h5n8ZWizaba3mjzyqkyTEbonzneF75IFeo+PdCt/EHhO90+4hSRSoeNTwA6nK0AfNfgTR7fQrBNQ1zT4brWL0+ZG1224rkE556fWvT9W0i21a1jl1e0tbhSNquiLgE9MZqprujWMVtYXOsXha88xI0SKPasrc4X3AqnPfajdeO4tH1BxpmnQ4kjRBvM5AznA4C9qAPO/ij4M1HTPDk19ZmJ9IicKyLCEaPJzwR1GTUX7P8A8Q7zw3qr6dd3Es2mzD5Ym3OFbPb0r6Gv9KtNSEUcsKXOnuD5qOPlPpxWbe/Djwzd3FhILJYVtMiI237vHOfmx15oA9B03WbS+VQrhJiBmNuCKvTwxzxGOaNJI24KuAwP4GufijtYf9WVJTjA+9VO3vrhtXEDl1jUkny3xgdsg80AUPE/wj8GeInaS70aGCdustqPKOfXjg1wV/8Asy+GpnY2erapbg9Adj4/QV7ZJfGIHgNjt3xSwalHPyi+x5HFAHga/svaVvy/iO+KeggQH+ddDo/7Ovg/T3D3DXt847TuNv5AV6VrOvyWNnJLDaiSRcfKzbQefWub8TeM73T9OaSSGO3VzsEkatIUJ6E47UAY/ivUPBPw3toYDDaQ3YT93HHGDIBjrwMivJYNf174oyTafbldM0QyEyXRYhmA/gB9cU3xrpdr4ovVhS5hmuFcPdXQciQKOwDetcd4u8WxWNidG8PrLaQphSVfGMcHp3PegDqPFnjDSPA2mP4d8Fx28sjIVuLv7xBPv3NeJXlzNdzGW4leRz1Zjk0x3LHJJJ96ZQAAYooooAKKKCOKAEJxSYqXySI98nyqenqaaSPSgBpFFOzRQA88mgUUmQKAFpjA4PPWlzwaRTgGgBopwPy0D5uTSEYNABnpzSAkGkINA96ANzwx4gvfD+oC7sXGcYdG+649CK7jRrr+1deh1vwuIbXU0/eT6fI+2OVh12n0I7V5YPY1JFK8bhkcqw6EHBFAH0W3xNtkfydcs5tPvkGxggJVD65HUV13h/xPZa7aySwXbSpZsrOiDn8D1r5x0fxlc24jivlW7t14Kv1Yeh9a9D8NePPCdozv9kkspX7wZTnuTjj6UAfRK3ZnjWWOdTEBkENkHjoajnvXjlWIkGVxgLzg+9eWWXijQrZMeHNetrdpcsyXDllLnuQelU5vHetWckrvr3hy5jTgHlWP4CgD2FRLIpEpjdOV5HU/1+tX7WKO2jCOU3Y4HXFfO0nxvurWcrLbWcxXjfEzEH3ANUNT+PGpmTGnWNsiDoZMk59+aAPpp44p33PGkhXhRIB+ntWVcX0caH7PdwIxOXVWAPXnFfNI+MniPV5/s1/f2lhayDDSx25JUe2Oc0mn6Z4MlnNxe+MLmWXO7BDpk5zycUAe3+LNZtNL0+71jU3EcaDFuVba3HoPU1zvw01FfE1j9ujQAtO+/cCzR85Chj0Hf8a4631jwBYTLLf6jd6q0IISO53Tp7kAitR/jL4a0zTRFpFg+VOREkQjXPv2oA766DeFboa5czXA0+1lDyI7rl1zycd8elN8WfH/AMJ2uiTtpEk9/eONqxeW0YGe5J9PavmHxx441TxbfGW9l2W4JCQITtUZz+Ncu3KnmgD2f4f+No729eDVCJZFm861aeTiMngjnPrUnjTxKll4ttJIdJlt7eNz512uSW3HnaR2FeJBypBDYI9K6LRvG+u6UBHbX7tDu3GOX51P4GgD6e8GeJbea1FzPeQw2smTC0knzntgg9Bmu1m1WGKx+2XM8C2iIXd93AHtXz1Y/GLSp7FE1XRk89R/yyjUqfwPStD/AIWF4J8S2y2OuQ3dnF0GQzR/ocigD2jwh4i0XX0mvdHufODn5mJIbjtg9K2UEUU7yoR9ok5L5ycA18ta9o3hnSNOmm8MeM2jjlyfIOWLY6DgZH41wuneMtf0xitnqt0o5H+sJyPxoA+4ri9ERVLhwxY7CEFZV5dw2oLRSkDPRuuT06da+Qbn4i+IbmNo7jUJpEbGVLmkt/iJrdrEqW0sUeBjds3H9c0AfTGt6oupRLFqAujDHKCY1cGRiDkcDt9a4fxtbapJeyT3WpvpGht80kMtxmRvZVArxS+8d+IrsfvNVnXPXyzsz+VYd3qN5etm7upp27GRy386AO78WeOLc6YdF8PW/lWKnJuJOZXPc5rztmLMSxyTSHmkyKAFop0Uck7hII3lc9kUk/pXS6F4dsFuEl8V6j/Z1rjf5SoWlf2Axx+NAHNKhY4UEn0FdDovgrXdXiaeC1ENsvJmuHEaD8TXZ6t4/wBI0vSoLLwNpsFskasss13EryyZPBGc/rXnWreINU1WRze308oc7ipc7fy6CgDcj0PQNOfGu64ZJFPMOnxeYff5mwP51q23jPQ9FtbmPw9oGLiQMq3N5IJGUEY6YxXngfPU06gB8sjSyM8jEsxySaZ3opDQApPNFJ+NFAEhFNI56VL3prdaAIyOPrSHPPFPboKQd6AGg47UjHnmnN1pGoAbk+lKTnrSnrSUAIOvAoIw3ApRT3/1g+lADVI+lKDyN2cd8Uh60qd/pQBKrR4kyHz/AA8/zqMsaU9DQ3UUAJmlo7UtACUhPFOpnpQAjE/pTM5FSS9KjX7tACDqKk3DmmnoKSgBoPPSg/ezRTj1oAVKdmhOtIelACg5pOhpU60DrQA2k9aee1JQAw0q8HpxSt0pRQAE+ldh4Z07wfGhuPEmqXUxC5FraQkFj6FjXHnpTloA7W78ePZRSWvhOxh0ezYEFkG+Zx7ucn8q4q5uJbiVpZnZ3bksxyTTaTvQA089qTHtUnpSjrQAwCnbjSjrQKAFzxTacKWgBuPaipG60UAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High resolution CT demonstrating a pleural effusion associated with a cavitating rheumatoid nodule. The patient presented with pleuritic chest pain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Fiona R Lake, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_18_36143=[""].join("\n");
var outline_f35_18_36143=null;
